Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (27876)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2018 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol 2018; 24(30): 3361-3373 [PMID: 30122876 DOI: 10.3748/wjg.v24.i30.3361] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i30/3361.htm |
| Number | Citing Articles |
| 1 |
Ludovico Abenavoli, Luigi Boccuto, Alessandro Federico, Marcello Dallio, Carmelina Loguercio, Laura Di Renzo, Antonino De Lorenzo. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. International Journal of Environmental Research and Public Health 2019; 16(17): 3011 doi: 10.3390/ijerph16173011
|
| 2 |
Sara Karjoo, Anthony Auriemma, Teresa Fraker, Harold Edward Bays. Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2022; 3: 100027 doi: 10.1016/j.obpill.2022.100027
|
| 3 |
Ridhi Deo, Suranjan Panigrahi. Explainability Analysis of Black Box SVM models for Hepatic Steatosis Screening. 2022 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT) 2022; : 22 doi: 10.1109/HI-POCT54491.2022.9744067
|
| 4 |
Chowdhury F Zaman, Jakia Sultana, Proma Dey, Jui Dutta, Sadia Mustarin, Nuzhat Tamanna, Aditi Roy, Nisha Bhowmick, Mousumi Khanam, Sadia Sultana, Selia Chowdhury, Farjana Khanam, Md Sakibuzzaman, Priyata Dutta. A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.29657
|
| 5 |
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, Jin Wang. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences 2022; 23(24): 15489 doi: 10.3390/ijms232415489
|
| 6 |
Khara Lucius. Nutritional and Botanical Approaches for Nonalcoholic Fatty Liver Disease. Alternative and Complementary Therapies 2020; 26(6): 246 doi: 10.1089/act.2020.29303.klu
|
| 7 |
Hua Liu, Yang-Min Hao, Sheng Jiang, Maiheliya Baihetiyaer, Cheng Li, Guo-Yao Sang, Zhiming Li, Guo-Li Du. Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment. International Journal of General Medicine 2024; : 2613 doi: 10.2147/IJGM.S460200
|
| 8 |
Yejin Kim, Yoosoo Chang, Min-Jung Kwon, Yun Soo Hong, Mi Kyung Kim, Won Sohn, Yong Kyun Cho, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults. American Journal of Gastroenterology 2021; 116(11): 2270 doi: 10.14309/ajg.0000000000001344
|
| 9 |
Ahmed Hashem, Yogesh Shastri, Malfi Al Otaibi, Elwin Buchel, Hussam Saleh, Reyaz Ahmad, Hamouda Ahmed, Fateh Al Idris, Saleh Ahmed, Mohamed Guda, Anton Gillessen. Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of Silymarin. Gastroenterology Insights 2021; 12(2): 155 doi: 10.3390/gastroent12020014
|
| 10 |
Arshad Mehmood, Lei Zhao, Yong Wang, Fei Pan, Shuai Hao, Huimin Zhang, Asra Iftikhar, Muhammad Usman. Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review. Food Research International 2021; 142: 110180 doi: 10.1016/j.foodres.2021.110180
|
| 11 |
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!. Metabolism 2019; 101: 154001 doi: 10.1016/j.metabol.2019.154001
|
| 12 |
Erenie Guirguis, Yasmin Grace, Anthony Bolson, Matthew J. DellaVecchia, Melissa Ruble. Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(3): 315 doi: 10.1002/phar.2489
|
| 13 |
Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, Benedicto Crespo Facorro. Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis. Data in Brief 2019; 27: 104415 doi: 10.1016/j.dib.2019.104415
|
| 14 |
Fangfei Xie, Yuyu Pei, Quan Zhou, Deli Cao, Yun Wang. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01560-3
|
| 15 |
Chanh-Phong Tran, John J Kim, Jordan J Feld, William WL Wong. Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluation. Canadian Liver Journal 2021; 4(4): 360 doi: 10.3138/canlivj-2021-0011
|
| 16 |
Shuangzhen Jia, Yuzhen Zhao, Jiaqi Liu, Xu Guo, Moxian Chen, Shaoming Zhou, Jianli Zhou. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy. Frontiers in Pediatrics 2022; 9 doi: 10.3389/fped.2021.784221
|
| 17 |
Jinyao Liu, Yumiko Oba, Seiko Yamano. Chronic ethanol consumption plus an atherogenic diet cause metabolic steatohepatitis with advanced liver fibrosis in apolipoprotein E/low‐density lipoprotein receptor double‐knockout mice. Alcoholism: Clinical and Experimental Research 2022; 46(7): 1192 doi: 10.1111/acer.14852
|
| 18 |
Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies. F1000Research 2023; 11: 223 doi: 10.12688/f1000research.109134.3
|
| 19 |
Francesco Tovoli, Silvia Ferri, Fabio Piscaglia. Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease. Current Pharmaceutical Design 2020; 26(32): 3909 doi: 10.2174/1381612826666200429093648
|
| 20 |
Kozue Kanemitsu-Okada, Masanori Abe, Yoshiko Nakamura, Teruki Miyake, Takao Watanabe, Osamu Yoshida, Yohei Koizumi, Masashi Hirooka, Yoshio Tokumoto, Bunzo Matsuura, Mitsuhito Koizumi, Yoichi Hiasa. Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2023; 24(3): 2509 doi: 10.3390/ijms24032509
|
| 21 |
Sheng Yang, Chong Liu, Xiaowen Ji, Xuemin Chen, Yun Wang, Rong Tao. The Role of Gold Nanorods in Detecting Circulating microRNAs as Biomarkers in Liver Diseases. Journal of Biomedical Nanotechnology 2023; 19(10): 1721 doi: 10.1166/jbn.2023.3676
|
| 22 |
Guanghui Deng, Chang Liu, Jiamin Zhao, Ming Wang, Yunjia Li, Menghan Yang, Haixin Ye, Junjie Li, Mengchen Qin, Chaofeng Wu, Hao Shi, Yuxin Liao, Zhaoxi Zhou, Shiqing Zhang, Ken Kin Lam Yung, Lei Gao. Exocarpium Citri Grandis alleviates the aggravation of NAFLD by mitigating lipid accumulation and iron metabolism disorders. Journal of Ethnopharmacology 2023; 313: 116559 doi: 10.1016/j.jep.2023.116559
|
| 23 |
Morteza Aghajanpoor, Mehrzad Gholampourdehaki, Reza Mosaed, Iraj Mirzaii-Dizgah, Afsaneh Vosughi. The Efficacy of Empagliflozin in Combination with Pioglitazone on the Improvement of Fatty Liver Disease in Patients with Type 2 Diabetes. Annals of Military and Health Sciences Research 2024; 22(2) doi: 10.5812/amh-144009
|
| 24 |
Nuojin Guo, Hekai Shi, Hao Zhang, Hua Wang. Comparison of the efficacy and safety of hypoglycemic treatments in patients with non-alcoholic fatty liver disease and type-2 diabetes: a systematic review and Bayesian network analysis. European Journal of Clinical Pharmacology 2023; 79(11): 1465 doi: 10.1007/s00228-023-03561-w
|
| 25 |
Yang Xia, Limin Cao, Qing Zhang, Li Liu, Shunming Zhang, Ge Meng, Hongmei Wu, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Adherence to a vegetable dietary pattern attenuates the risk of non‐alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort study. Journal of Internal Medicine 2022; 291(4): 469 doi: 10.1111/joim.13428
|
| 26 |
Xiaoyan Li, Hua Wang. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00507-y
|
| 27 |
Ruojia Ma, Yike Zhan, Yamei Zhang, Liangan Wu, Xing Wang, Ming Guo. Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic mice. Drug Development Research 2021; doi: 10.1002/ddr.21905
|
| 28 |
Laya Hooshmand Gharabagh, Ali Shargh, Mohammad Reza Mohammad Hosseini Azar, Ayda Esmaeili. Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease. Clinics and Research in Hepatology and Gastroenterology 2024; 48(3): 102279 doi: 10.1016/j.clinre.2023.102279
|
| 29 |
Oh Young Kwon, Mi Kyung Lee, Hye Won Lee, Hyerang Kim, Jae Seung Lee, Yeonsoo Jang. Mobile App–Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial. Journal of Medical Internet Research 2024; 26: e49839 doi: 10.2196/49839
|
| 30 |
Inês H. Vieira, Luísa M. Barros, Carla F. Baptista, Dírcea M. Rodrigues, Isabel M. Paiva. Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes. Clinical Diabetes 2022; 40(1): 97 doi: 10.2337/cd21-0043
|
| 31 |
Anastasios Semertzidis, Thomai Mouskeftara, Helen Gika, Petros Pousinis, Kali Makedou, Antonis Goulas, Jannis Kountouras, Stergios A. Polyzos. Effects of Combined Low-Dose Spironolactone Plus Vitamin E versus Vitamin E Monotherapy on Lipidomic Profile in Non-Alcoholic Fatty Liver Disease: A Post Hoc Analysis of a Randomized Controlled Trial. Journal of Clinical Medicine 2024; 13(13): 3798 doi: 10.3390/jcm13133798
|
| 32 |
Jörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, Elisabetta Bugianesi, Branko Popovic. Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review. Expert Review of Gastroenterology & Hepatology 2021; 15(11): 1253 doi: 10.1080/17474124.2021.1974295
|
| 33 |
Dominic S. Ng. Emerging insight into the role of cellular cholesterol in the pathogenesis of nonalcoholic steatohepatitis progression. Current Opinion in Lipidology 2020; 31(4): 262 doi: 10.1097/MOL.0000000000000693
|
| 34 |
Banshi Saboo, Sanjay Agarwal, Brij Mohan Makkar, Rajeev Chawla, Sujoy Ghosh, Vijay Viswanathan, Sunil Gupta, Ch. Vasanth Kumar, Anuj Maheshwari, L. Sreenivasamurthy, Rakesh Kumar Sahay, Sanjay Reddy, Shalini Jaggi, Jugal Kishor Sharma, Vijay Panikar, Anand Moses, Bikash Bhattacharjee, Pratap Jethwani, Sudhir Bhandari, J. P. S. Sawhney, Shashank Joshi, Saumitra Ray, S. V. Madhu, Bipin Sethi. RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus. International Journal of Diabetes in Developing Countries 2022; 42(1): 3 doi: 10.1007/s13410-022-01063-6
|
| 35 |
Jonathan Mertens, Christophe De Block, Maarten Spinhoven, Ann Driessen, Sven M. Francque, Wilhelmus J. Kwanten. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.768576
|
| 36 |
David Brain, Amarzaya Jadambaa, Sanjeewa Kularatna. Methodology to derive preference for health screening programmes using discrete choice experiments: a scoping review. BMC Health Services Research 2022; 22(1) doi: 10.1186/s12913-022-08464-7
|
| 37 |
Muhammad Radzi Abu Hassan, Rosaida Hj Md Said, Zalwani Zainuddin, Haniza Omar, Siti Maisarah Md Ali, Siti Aishah Aris, Huan-Keat Chan. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Heliyon 2023; 9(6): e16652 doi: 10.1016/j.heliyon.2023.e16652
|
| 38 |
Yang Xia, Shunming Zhang, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Xue Bao, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Insoluble dietary fibre intake is associated with lower prevalence of newly-diagnosed non-alcoholic fatty liver disease in Chinese men: a large population-based cross-sectional study. Nutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-019-0420-1
|
| 39 |
Rodrigo Valenzuela, Luis A. Videla. Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View. Nutrients 2020; 12(2): 499 doi: 10.3390/nu12020499
|
| 40 |
Yuling Song, Boru Chen, Lu Jiang, Fangkun Zhao, Xiuqin Feng. Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric
and Mapping Analysis. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(5): 573 doi: 10.2174/0118715303230418230925060312
|
| 41 |
Harold E. Bays, Amit Khera, Michael J. Blaha, Matthew J Budoff, Peter P. Toth. Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”). American Journal of Preventive Cardiology 2021; 6: 100176 doi: 10.1016/j.ajpc.2021.100176
|
| 42 |
Natalia O. Nosko, Viacheslav V. Kharchenko. INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE. Wiadomości Lekarskie 2021; 74(10): 2593 doi: 10.36740/WLek202110212
|
| 43 |
Zhixin Zhang, Jiahui Wang, Yan Lin, Juan Chen, Jian Liu, Xian Zhang. Nutritional activities of luteolin in obesity and associated metabolic diseases: an eye on adipose tissues. Critical Reviews in Food Science and Nutrition 2024; 64(12): 4016 doi: 10.1080/10408398.2022.2138257
|
| 44 |
Anne M. Misher, Jennifer L. Rosselli, Christine A. Schumacher, Michael See. The Role of the Diabetes Care and Education Specialist in Caring for Diabetes Complications and Common Comorbid Conditions. ADCES in Practice 2021; 9(3): 30 doi: 10.1177/2633559X211002805
|
| 45 |
Josephine Skat-Rørdam, Kamilla Pedersen, Gry Freja Skovsted, Ida Gregersen, Sara Vangsgaard, David H. Ipsen, Markus Latta, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea Pig. Antioxidants 2021; 11(1): 69 doi: 10.3390/antiox11010069
|
| 46 |
Annamaria Sila, Sara De Nucci, Caterina Bonfiglio, Vincenza Di Stasi, Nicole Cerabino, Martina Di Chito, Roberta Rinaldi, Paola Cantalice, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Nicoletta Maria Tutino, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity. Nutrients 2024; 16(6): 874 doi: 10.3390/nu16060874
|
| 47 |
Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, Laura Canesi, Ilaria Demori. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. Planta Medica 2022; 88(01): 9 doi: 10.1055/a-1273-3159
|
| 48 |
Галина Корнован , Володимир Синенко , Лариса Колотвіна , Яна Бажора , Дарʼя Лагода , Вероніка Назарян , Ганна Амірова , Олена Паслар . КОМОРБІДНА ПАТОЛОГІЯ ПЕЧІНКИ У ПАЦІЄНТІВ, ЯКІ ЖИВУТЬ З ОЖИРІННЯМ. Grail of Science 2022; (17): 419 doi: 10.36074/grail-of-science.22.07.2022.073
|
| 49 |
Kenny Mendoza, Víctor Eduardo Villalobos-Daniel, Alejandra Jáuregui, Isabel Valero-Morales, César Hernández-Alcaraz, Nelson Zacarías-Alejandro, Ricardo Omar Alarcon-Guevara, Simón Barquera. Development of a crowdsourcing- and gamification-based mobile application to collect epidemiological information and promote healthy lifestyles in Mexico. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56761-4
|
| 50 |
Fangzhi Yue, Ying Shi, Shanyu Wu, Lin Xing, Dan He, Lin Wei, Anqi Qiu, Ryan Russell, Dongmei Zhang. Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD. iScience 2023; 26(12): 108560 doi: 10.1016/j.isci.2023.108560
|
| 51 |
Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies. F1000Research 2022; 11: 223 doi: 10.12688/f1000research.109134.1
|
| 52 |
Rui Tavares, Mireia Alemany-Pagès, Sara Araújo, Neil Cohn, João Ramalho-Santos, Anabela Marisa Azul. Comics in Science and Health Communication: Insights From Mutual Collaboration and Framing a Research Practice. International Journal of Qualitative Methods 2023; 22 doi: 10.1177/16094069231183118
|
| 53 |
Di Wang, Bing-Yan Zhou, Lei Xiang, Xu-Yong Chen, Jie-Xiong Feng. Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(25): 3132-3139 doi: 10.3748/wjg.v30.i25.3132
|
| 54 |
Martin M. Grajower. Nonalcoholic Steatohepatitis. JAMA 2020; 324(9): 899 doi: 10.1001/jama.2020.10434
|
| 55 |
Marco Arrese, Francisco Barrera, Nicolas Triantafilo, Juan Pablo Arab. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations. Expert Review of Gastroenterology & Hepatology 2019; 13(9): 849 doi: 10.1080/17474124.2019.1649981
|
| 56 |
Guoqiong Xu, Yuanyuan Wu, Jie Chen, Dan Xiang, Dongji Li. The relationship between muscle mass and fat content in body composition and non-alcoholic fatty liver disease in the Chinese general population: a cross-sectional study. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1384366
|
| 57 |
Robert Beaumont Wilson, Yicong Liang, Devesh Kaushal, Anitra Carr. Molecular Pharmacology of Vitamin C and Relevance to Health and Obesity—A Narrative Review. International Journal of Molecular Sciences 2024; 25(14): 7523 doi: 10.3390/ijms25147523
|
| 58 |
T. N. Alexandrova, O. Ya. Babak . Effects of Ademetionine on Liver Fibrosis, Level of Pentraxin-3 and Metabolic Indicators in Patients with Comorbid Course of Non-alcoholic Liver Disease and Arterial Hypertension. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2020; 5(6): 95 doi: 10.26693/jmbs05.06.095
|
| 59 |
Somaya Albhaisi. Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?. EMJ Hepatology 2019; : 80 doi: 10.33590/emjhepatol/10311541
|
| 60 |
Chayanis Kositamongkol, Sukrit Kanchanasurakit, Chiraphong Auttamalang, Nutkamon Inchai, Thanatchaporn Kabkaew, Sarunporn Kitpark, Nathorn Chaiyakunapruk, Acharaporn Duangjai, Surasak Saokaew, Pochamana Phisalprapa. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.786596
|
| 61 |
Luis Vega, Daniela Simian, Abraham I. Gajardo, Marcelo Salinas, Andrea Urra, Máximo Cattaneo, Rosario Pino, Juan P. Roblero, Álvaro Urzúa, Katherine Rojas, Jaime Poniachik. Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis. Annals of Hepatology 2024; 29(4): 101511 doi: 10.1016/j.aohep.2024.101511
|
| 62 |
David Hermanus Wessels, Zeil Rosenberg. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?. World Journal of Hepatology 2021; 13(2): 233-241 doi: 10.4254/wjh.v13.i2.233
|
| 63 |
Sina Ghandian, Rahul Thapa, Anurag Garikipati, Gina Barnes, Abigail Green‐Saxena, Jacob Calvert, Qingqing Mao, Ritankar Das. Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis. JGH Open 2022; 6(3): 196 doi: 10.1002/jgh3.12716
|
| 64 |
Leilei Yu, Ruohan Zhao, Chen Wang, Chengcheng Zhang, Chuanqi Chu, Jianxin Zhao, Hao Zhang, Qixiao Zhai, Wei Chen, Heng Zhang, Fengwei Tian. Effects of garlic supplementation on non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Journal of Functional Foods 2022; 99: 105294 doi: 10.1016/j.jff.2022.105294
|
| 65 |
Rachelle Haber, Fatima Zarzour, Malak Ghezzawi, Natalie Saadeh, Dania S. Bacha, Lama Al Jebbawi, Marlene Chakhtoura, Christos S. Mantzoros. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism 2024; 26(5): 1850 doi: 10.1111/dom.15501
|
| 66 |
Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study. Ultrasound in Medicine & Biology 2022; 48(9): 1797 doi: 10.1016/j.ultrasmedbio.2022.05.005
|
| 67 |
Yang Xia, Qijun Wu, Huixu Dai, Jiale Lv, Yashu Liu, Hui Sun, Yuting Jiang, Qing Chang, Kaijun Niu, Yuhong Zhao. Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.642509
|
| 68 |
Ruihong Dai, Miaomiao Sun, Mei Lu, Lanhua Deng. Deep learning for predicting fibrotic progression risk in diabetic individuals with metabolic dysfunction-associated steatotic liver disease initially free of hepatic fibrosis. Heliyon 2024; 10(13): e34150 doi: 10.1016/j.heliyon.2024.e34150
|
| 69 |
Manouchehr Khoshbaten, Samineh Beheshtirouy, Shahrzad Shayanrad, Afshin Gharekhani, Haleh Rezaee. Comparison of the efficacy of pioglitazone and metformin on
ultrasound grade and liver enzymes level in patients with non-alcoholic fatty
liver disease: A randomized controlled clinical trial. Drug Research 2023; 73(04): 232 doi: 10.1055/a-1997-0401
|
| 70 |
Dimitrios A. Koutoukidis, Sandi Yen, Paula Gomez Castro, Mariya Misheva, Susan A. Jebb, Paul Aveyard, Jeremy W. Tomlinson, Ferenc E. Mozes, Jeremy F. Cobbold, Jethro S. Johnson, Julian R. Marchesi. Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2392864
|
| 71 |
Kamil Synoradzki, Paweł Grieb. Citicoline: A Superior Form of Choline?. Nutrients 2019; 11(7): 1569 doi: 10.3390/nu11071569
|
| 72 |
Zhuo Wei, Dan Zhao, Ye Zhang, Yuanli Chen, Shuang Zhang, Qi Li, Peng Zeng, Xiaoju Li, Wenwen Zhang, Yajun Duan, Jihong Han, Xiaoxiao Yang. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner. Biochemical and Biophysical Research Communications 2019; 519(4): 854 doi: 10.1016/j.bbrc.2019.09.084
|
| 73 |
Sahar H. Elhini, Engy A. Wahsh, Ahmed A. Elberry, Nadia F. El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A. Elsayed, Hoda M. Rabea. The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals 2022; 15(12): 1516 doi: 10.3390/ph15121516
|
| 74 |
Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2023; 42(6): 987 doi: 10.1016/j.clnu.2023.03.021
|
| 75 |
Jae-Hyung Roh, Hanbyul Lee, Bae Yun-Jeong, Chan Sun Park, Hyo-Jung Kim, Sun-Young Yoon, Huei-Kai Huang. A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults. PLOS ONE 2022; 17(1): e0262715 doi: 10.1371/journal.pone.0262715
|
| 76 |
Joana Rigor, Andreia Diegues, José Presa, Pedro Barata, Daniela Martins-Mendes. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population. Postgraduate Medicine 2022; 134(4): 435 doi: 10.1080/00325481.2022.2058285
|
| 77 |
Somaya Albhaisi. Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?. European Medical Journal 2019; : 57 doi: 10.33590/emj/10310531
|
| 78 |
Hideyuki Tamai, Jumpei Okamura, Kishio Nanjo. Moderate‐carbohydrate diet without caloric or lipid restriction for Japanese adult patients with nonalcoholic fatty liver disease: A prospective cohort study. Hepatology Research 2023; 53(12): 1185 doi: 10.1111/hepr.13954
|
| 79 |
Mahboobe Hosseinikia, Farhad Oubari, Roghaye Hosseinkia, Zibaneh Tabeshfar, Mohammad Gharib Salehi, Zeinab Mousavian, Mehrnaz Abbasi, Mehnoosh Samadi, Yahya Pasdar. Quercetin supplementation in non-alcoholic fatty liver disease. Nutrition & Food Science
2020; 50(6): 1279 doi: 10.1108/NFS-10-2019-0321
|
| 80 |
Abeer Abdel-latif, Ula Mabid Al-Jarhi, Dina Hesham, Mona khozam, Shaimaa A. Fathy. Sex hormone binding globulin (SHBG) as a predictor of liver fibrosis in subjects with nonalcoholic fatty liver disease (NAFLD). The Egyptian Journal of Internal Medicine 2023; 35(1) doi: 10.1186/s43162-023-00220-5
|
| 81 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
|
| 82 |
Di Cao, Mengyi Li, Yang Liu, He Jin, Dawei Yang, Hui Xu, Han Lv, JIa Liu, Peng Zhang, Zhongtao Zhang, Zhenghan Yang. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00821-6
|
| 83 |
Cai-yan Zou, Yan Sun, Jun Liang. Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,. Clinics and Research in Hepatology and Gastroenterology 2023; 47(1): 102053 doi: 10.1016/j.clinre.2022.102053
|
| 84 |
Èlia Navarro-Masip, Nuria Mestres Petit, Blanca Salinas-Roca , Fernando Herrerías, Felip Vilardell, Mari Cruz de la Fuente, Judit Pallares, Maite Santamaría, Marta Zorzano-Martínez, Enric Sánchez , Xavier Matías-Guiu , Carolina López-Cano, Ana Gloria Soler, Josep León-Mengíbar, Marta Bueno, Albert Lecube. Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver®) Diagnoses. Obesity Facts 2024; 17(5): 473 doi: 10.1159/000538765
|
| 85 |
Dóra Mátis, Péter Hegyi, Brigitta Teutsch, Tamás Tornai, Bálint Erőss, Gabriella Pár, Szilárd Váncsa. Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1114836
|
| 86 |
Bitasta Mandal, Rakesh Das, Sandip Mondal. Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease. Annales Pharmaceutiques Françaises 2024; 82(3): 373 doi: 10.1016/j.pharma.2024.02.005
|
| 87 |
Sayed Mohammad Hosseeini, Mohammad Jafari, Marzieh Tahmasebi, Payman Adibi. Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province. International Journal of Preventive Medicine 2024; 15 doi: 10.4103/ijpvm.ijpvm_284_22
|
| 88 |
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
|
| 89 |
John A. Dougherty, Erenie Guirguis, Krisy-Ann Thornby. A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease. Annals of Pharmacotherapy 2021; 55(1): 65 doi: 10.1177/1060028020935105
|
| 90 |
Feryal Savari, Seyed Ali Mard. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment. Heliyon 2024; 10(7): e28468 doi: 10.1016/j.heliyon.2024.e28468
|
| 91 |
Mary P. Moore, Rory P. Cunningham, Rachel A. H. Davis, Sarah E. Deemer, Brandon M. Roberts, Eric P. Plaisance, R. Scott Rector. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(4): G564 doi: 10.1152/ajpgi.00259.2020
|
| 92 |
Kamlesh K. Bhopale, Mukund P. Srinivasan. Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). Livers 2023; 3(4): 597 doi: 10.3390/livers3040040
|
| 93 |
M. Zhang, W.J. Tu, Q. Zhang, X.L. Wu, X.Y. Zou, S. Jiang. Osteocalcin reduces fat accumulation and inflammatory reaction by inhibiting ROS-JNK signal pathway in chicken embryonic hepatocytes. Poultry Science 2022; 101(11): 102026 doi: 10.1016/j.psj.2022.102026
|
| 94 |
Wen Fan, Kairui Tang, Yuanjun Deng, Chuiyang Zheng, Maoxing Pan, Dajin Pi, Zheng Liang, Jianwei Zhen, Qinhe Yang, Yupei Zhang. Bifidobacterium lactis Probio‐M8 prevents nonalcoholic fatty liver disease in high‐fat diet‐fed rats: The potential role in modulating gut microbiota. Food Bioengineering 2024; 3(1): 29 doi: 10.1002/fbe2.12076
|
| 95 |
Zhaowei Dong, Jingjing Yang, Maoying Tian, Xi Wang, Xiaoyan Qin, Qinwan Huang, Jin Wang. Mechanism of Bile‐Processed Coptidis Rhizoma to Treat Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Based on UPLC‐Q‐TOF/MS and Network Pharmacology. ChemistrySelect 2023; 8(13) doi: 10.1002/slct.202204236
|
| 96 |
Jennifer Linge, Patrik Nasr, Arun J. Sanyal, Olof Dahlqvist Leinhard, Mattias Ekstedt. Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD. JHEP Reports 2023; 5(3): 100663 doi: 10.1016/j.jhepr.2022.100663
|
| 97 |
Jinyun Li, Lu Fang, Miaocui Xi, Anyu Ni, Qiuhui Qian, Zejun Wang, Huili Wang, Jin Yan. Toxic effects of triclosan on hepatic and intestinal lipid accumulation in zebrafish via regulation of m6A-RNA methylation. Aquatic Toxicology 2024; 269: 106884 doi: 10.1016/j.aquatox.2024.106884
|
| 98 |
Nonalcoholic Steatohepatitis: Case-Based Focused on Pediatric and Adult Guidelines. Osteopathic Family Physician 2021; 13(2): 29 doi: 10.33181/13024
|
| 99 |
Lu Zhong, Xiaojuan Peng, Chutian Wu, Qing Li, Yanfang Chen, Min Wang, Yuting Li, Kaiyin He, Ying Shi, Caiqun Bie, Shaohui Tang. Polysaccharides and flavonoids from cyclocarya paliurus modulate gut microbiota and attenuate hepatic steatosis, hyperglycemia, and hyperlipidemia in nonalcoholic fatty liver disease rats with type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries 2023; 43(2): 317 doi: 10.1007/s13410-022-01080-5
|
| 100 |
Maximilian J. Ganz, Sascha T. Bender, Christian Gross, Katrin Bose, Peter R. Mertens, Florian G. Scurt. Metabolisches Syndrom und Nierenkrankheiten. Die Nephrologie 2022; 17(5): 291 doi: 10.1007/s11560-022-00595-6
|
| 101 |
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A. Hill, Dimitri P. Mikhailidis, Christos S. Mantzoros, Ali Eid. Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological Reviews 2024; 76(3): 454 doi: 10.1124/pharmrev.123.001087
|
| 102 |
Yiwei Ma, Xinyue Ding, Jie Gu, Shengmin Zhou, Yuanrong Jiang. Effects of olive oil on hepatic steatosis and liver enzymes: A systematic review. Journal of Functional Foods 2023; 109: 105815 doi: 10.1016/j.jff.2023.105815
|
| 103 |
Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of view. Exploration of Medicine 2020; 1(3): 85 doi: 10.37349/emed.2020.00007
|
| 104 |
Yuichiro Eguchi, Gabriel Wong, Omar Akhtar, Yoshio Sumida. Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review. Hepatology Research 2020; 50(6): 645 doi: 10.1111/hepr.13502
|
| 105 |
Karolina Grąt, Michał Grąt, Olgierd Rowiński. Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2020; 8(9): 298 doi: 10.3390/biomedicines8090298
|
| 106 |
|
| 107 |
Peyda Korhan, Ezgi Bağırsakçı, Yasemin Öztemur Islakoğlu, Gülhas Solmaz, Burcu Sarıkaya, Deniz Nart, Funda Yılmaz, Neşe Atabey. MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma. Hepatoma Research 2024; doi: 10.20517/2394-5079.2023.140
|
| 108 |
Eric R. Yoo, Donghee Kim, Luis M. Vazquez‐Montesino, Jessica A. Escober, Andrew A. Li, Sean P. Tighe, Christopher T. Fernandes, George Cholankeril, Aijaz Ahmed. Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality. Liver International 2020; 40(4): 815 doi: 10.1111/liv.14374
|
| 109 |
Kim Sui Wan, Halizah Mat Rifin, Muhammad Fadhli Mohd Yusoff, Kishwen Kanna Yoga Ratnam, Wah Kheong Chan, Masni Mohamad, Nurain Mohd Noor, Feisul Mustapha, Noor Ani Ahmad. Prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease in Malaysia 2023: study protocol for a community-based nationwide cross-sectional survey. BMJ Open 2023; 13(10): e074432 doi: 10.1136/bmjopen-2023-074432
|
| 110 |
Chiara Zusi, Alessandro Mantovani, Francesca Olivieri, Anita Morandi, Massimiliano Corradi, Emanuele Miraglia Del Giudice, Marco Dauriz, Luca Valenti, Christopher D. Byrne, Giovanni Targher, Claudio Maffeis. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents. Digestive and Liver Disease 2019; 51(11): 1586 doi: 10.1016/j.dld.2019.05.029
|
| 111 |
Alessia De Masi, Xiaoxu Li, Dohyun Lee, Jongsu Jeon, Qi Wang, Seoyeong Baek, Onyu Park, Adrienne Mottis, Keno Strotjohann, Alexis Rapin, Hoe-Yune Jung, Johan Auwerx. Cyclo(His-Pro): A further step in the management of steatohepatitis. JHEP Reports 2023; 5(9): 100815 doi: 10.1016/j.jhepr.2023.100815
|
| 112 |
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A. A. Abdel‐Ghany, Mohamed O. Mahmoud. Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway. Archiv der Pharmazie 2024; 357(4) doi: 10.1002/ardp.202300631
|
| 113 |
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. World Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
|
| 114 |
Tongxi Zhuang, Wei Li, Li Yang, Zhengtao Wang, Lili Ding, Mingmei Zhou. Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.731288
|
| 115 |
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(16): 5888 doi: 10.3390/ijms21165888
|
| 116 |
Dóra Mátis, Brigitta Teutsch, Szilárd Váncsa. Improved body composition is associated with reduced steatosis in non-alcoholic fatty liver disease, a systematic review and meta-analysis of longitudinal studies. Bulletin of Medical Sciences 2022; 95(1): 89 doi: 10.2478/orvtudert-2022-0006
|
| 117 |
Fangfei Xie, Hong Zhou, Yun Wang. Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1112-6
|
| 118 |
J.M. Carrascosa, E. Vilarrasa, I. Belinchón, P. Herranz, J. Crespo, F. Guimerá, A. Olveira. [Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts. Actas Dermo-Sifiliográficas 2023; 114(5): T392 doi: 10.1016/j.ad.2023.04.013
|
| 119 |
Da Hyun Lee, Jai J. Jee, Yu Seol Lee, Da Ye Kim, Ji Yun Bang, Hye Won Lee, Hong Koh, Soo Han Bae. Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH. Digestive and Liver Disease 2023; 55(11): 1521 doi: 10.1016/j.dld.2023.06.015
|
| 120 |
Stefano Ciardullo, Tommaso Monti, Gianluca Perseghin. Lack of awareness of liver organ damage in patients with type 2 diabetes. Acta Diabetologica 2021; 58(5): 651 doi: 10.1007/s00592-021-01677-y
|
| 121 |
David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still. “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”. Obesity Science & Practice 2021; 7(5): 629 doi: 10.1002/osp4.509
|
| 122 |
Alessio Aghemo, Olga P. Alekseeva, Francesco Angelico, Igor G. Bakulin, Natalia V. Bakulina, Dmitry Bordin, Alexey O. Bueverov, Oxana M. Drapkina, Anton Gillessen, Elvira M. Kagarmanova, Natalia V. Korochanskaya, U. A. Kucheryavii, Leonid B. Lazebnik, Maria A. Livzan, Igor V. Maev, Anatolii I. Martynov, Marina F. Osipenko, Evgenii I. Sas, Antonina Starodubova, Yurii P. Uspensky, Elena V. Vinnitskaya, Emilia P. Yakovenko, Alexey A. Yakovlev. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review. Annals of Medicine 2022; 54(1): 1548 doi: 10.1080/07853890.2022.2069854
|
| 123 |
Yu Zhu, Hu Yang, Shaoxian Liang, Honghua Zhang, Yufeng Mo, Songxian Rao, Yaozong Zhang, Zhuang Zhang, Weiqiang Wang, Wanshui Yang. Higher Adherence to Healthy Lifestyle Score Is Associated with Lower Odds of Non-Alcoholic Fatty Liver Disease. Nutrients 2022; 14(21): 4462 doi: 10.3390/nu14214462
|
| 124 |
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica (English Edition) 2022; 158(11): 550 doi: 10.1016/j.medcle.2022.05.009
|
| 125 |
Minal Patel. Evidence-based management of patients with nonalcoholic fatty liver disease. JAAPA 2022; 35(8): 20 doi: 10.1097/01.JAA.0000840492.53680.59
|
| 126 |
Lvying Wu, Lei Xing, Yake Zou, Zichen Wang, Yuanyuan Gou, Lei Zhang, Su Guan. UPLC-QTOF-MS Based Comparison of Rotundic Acid Metabolic Profiles in Normal and NAFLD Rats. Metabolites 2022; 13(1): 38 doi: 10.3390/metabo13010038
|
| 127 |
Guanghui Deng, Junjie Li, Manping Huang, Yunjia Li, Hao Shi, Chaofeng Wu, Jiamin Zhao, Mengchen Qin, Chang Liu, Menghan Yang, Yunqing Wang, Yuxue Zhang, Yuxin Liao, Chuying Zhou, Jian Yang, Yunsheng Xu, Bin Liu, Lei Gao. Erchen decoction alleviates the progression of NAFLD by inhibiting lipid accumulation and iron overload through Caveolin-1 signaling. Journal of Ethnopharmacology 2024; 319: 117320 doi: 10.1016/j.jep.2023.117320
|
| 128 |
Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa. The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review. Endocrine and Metabolic Science 2021; 3: 100089 doi: 10.1016/j.endmts.2021.100089
|
| 129 |
Stavroula Zagkou, Valentine Marais, Narimane Zeghoudi, Edouard Le Guillou, Eeva-Liisa Eskelinen, Ganna Panasyuk, Bernard Verrier, Charlotte Primard. Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation. Pharmaceutics 2022; 14(7): 1379 doi: 10.3390/pharmaceutics14071379
|
| 130 |
Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Emanuela Zappulo, Riccardo Scotto, Biagio Pinchera, Ivan Gentile. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi. Reviews on Recent Clinical Trials 2019; 14(2): 129 doi: 10.2174/1574887114666181204102516
|
| 131 |
Xin Tang, Yongkang Zhou, Fei Liu, Botao Wang, Bingyong Mao, Qiuxiang Zhang, Jianxin Zhao, Wei Chen, Shumao Cui. A Pueraria lobata root extract alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating the gut microbiota and associated metabolites. Food Bioscience 2024; 59: 103746 doi: 10.1016/j.fbio.2024.103746
|
| 132 |
Yuxiu Liu, Shiying Liu, Jiaofeng Huang, Yueyong Zhu, Su Lin. Validation of five hepatic steatosis algorithms in metabolic‐associated fatty liver disease: A population based study. Journal of Gastroenterology and Hepatology 2022; 37(5): 938 doi: 10.1111/jgh.15799
|
| 133 |
Yurou Xu, Youyi Wang, Qi Zhao, Bo Chen, Na Wang, Tiejun Zhang, Yonggen Jiang, Yiling Wu, Na He, Genming Zhao, Xing Liu. Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population. Hepatology International 2024; 18(2): 529 doi: 10.1007/s12072-024-10638-w
|
| 134 |
Vahid Sheikhi, Zahra Heidari. Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Advanced Biomedical Research 2022; 11(1): 124 doi: 10.4103/abr.abr_15_21
|
| 135 |
Jinchunzi Yang, Elisa Félix-Soriano, Alejandro Martínez-Gayo, Javier Ibañez-Santos, Neira Sáinz, J Alfredo Martínez, María J. Moreno-Aliaga. SIRT1 and FOXO1 role on MASLD risk: effects of DHA-rich n-3 PUFA supplementation and exercise in aged obese female mice and in post-menopausal overweight/obese women. Journal of Physiology and Biochemistry 2024; 80(3): 697 doi: 10.1007/s13105-024-01044-9
|
| 136 |
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver. Journal of the Chinese Medical Association 2021; 84(9): 842 doi: 10.1097/JCMA.0000000000000585
|
| 137 |
Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M. Ashworth Dirac, Sven Francque, Jacob George, Hannes Hagström, Terry T.-K. Huang, Mona H. Ismail, Achim Kautz, Shiv Kumar Sarin, Rohit Loomba, Veronica Miller, Philip N. Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero-Gómez, Jörn M. Schattenberg, Emmanuel A. Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M. Younossi, Shira Zelber-Sagi, Fredrik Åberg, Leon Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramon Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourliere, Radan Bruha, Elisabetta Bugianesi, Patrizia Burra, Maria Buti, Christopher D. Byrne, Jose Luis Calleja, Patrizia Carrieri, Flloyd Carter, Marlen Ivon Castellanos Fernandez, Gabriela Castillo-Lopez, Graciela E. Castro-Narro, Henry Lik Yuen Chan, Wah-Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen Corey, Antonio Craxi, Donna Cryer, Anuradha Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Ledinghen, Stefano DelPrato, Alessandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El Kassas, Osama M. Elsanousi, Gamal Esmat, Jian-Gao Fan, Nathalie Farpour-Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino A. Gani, Lynn Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon-Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch, Ingrid J. Hickman, Samantha L. Hocking, Bela Hunyady, Ramazan Idilman, Vasily A. Isakov, Mohammad H. Jamal, Peter Jepsen, Natacha Jreige Iskandar, Myeong Jun Song, K. C. Sudhamshu, Satoru Kakizaki, George Kalamitsis, Fasiha Kanwal, Jia-Horng Kao, Lee Kaplan, Takumi Kawaguchi, Yousef Khader, Seung Up Kim, Nicolas Kodjoh, Ger Koek, Kazuhiko Koike, Narcisse Patrice Komas, Marko Korenjak, Marcelo Kugelmas, Asma Labidi, Naomi F. Lange, Joel E. Lavine, Mariana Lazo, Nancy Lee, Cosmas Rinaldi A. Lesmana, Chun-Jen Liu, Michelle T. Long, Patricio Lopez-Jaramillo, Reza Malekzadeh, Mamun Al Mahtab, Giulio Marchesini, Rui Marinho, Sophia E. Martínez Vázquez, Lyudmila Mateva, Charles Mbendi Nlombi, Pascal Melin, Ivana Mikolasevic, Tamara Milovanovic, Carla Musso, Atsushi Nakajima, Edna Nava, Alexander V. Nersesov, Dafina Nikolova, Suzanne Norris, Katja Novak, Jude Oben, Janus P. Ong, Charles Onyekwere, George Papatheodoridis, Imran Paruk, Keyur Patel, M. Paula Macedo, Carlos Penha-Gonçalves, Marlene Pérez Figueroa, Wolf Peter Hofmann, Salvatore Petta, Claudia Pinto Marques Souza de Oliveira, Puneet Puri, Calvin Q. Pan, Marek Rac, Johanna Ralston, Alnoor Ramji, Homie Razavi, Mario Reis Alvares-da-Silva, Stuart Roberts, Michael Roden, Tamsin Rose, Samir Rouabhia, Patrizia Rovere-Querini, Ian A. Rowe, Shakhlo Sadirova, Riina Salupere, Tobokalova Saparbu, Raymond Sayegh, Giada Sebastiani, Yosuke Seki, Josefina Selmo, Abdel Karim Serme, Jonathan E. Shaw, Thrivikrama Shenoy, Nick Sheron, Oren Shibolet, Marcelo Silva, Igor Skrypnyk, Piotr Socha, Joan Soriano, C. Wendy Spearman, Kannan Sridharan, Juan José Suárez, Dhastagir Sultan Sheriff, Ki-Chul Sung, Mark Swain, Frank Tacke, Shahrad Taheri, Soek-Siam Tan, Elliot B. Tapper, Hannele Yki-Järvinen, Maja Thiele, Isaac Thom Shawa, Ieva Tolmane, Esther A. Torres, Michael Trauner, Sombat Treeprasertsuk, Adela Turcanu, Jonas Valantinas, Mette Vesterhus, Imam Waked, Sarah H. Wild, Jose Willemse, Robert J. Wong, Stavra Xanthakos, Dan Yock Young, Ming-Lung Yu, Kenneth I. Zheng, Mudjat Zeybel, Ming-Hua Zheng. Advancing the global public health agenda for NAFLD: a consensus statement. Nature Reviews Gastroenterology & Hepatology 2022; 19(1): 60 doi: 10.1038/s41575-021-00523-4
|
| 138 |
Ewa Garbiec, Judyta Cielecka-Piontek, Magdalena Kowalówka, Magdalena Hołubiec, Przemysław Zalewski. Genistein—Opportunities Related to an Interesting Molecule of Natural Origin. Molecules 2022; 27(3): 815 doi: 10.3390/molecules27030815
|
| 139 |
Halyna Kuznietsova, Oksana Lynchak, Natalia Dziubenko, Tetyana Herheliuk, Yuriy Prylutskyy, Volodymyr Rybalchenko, Uwe Ritter. Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injury. BioImpacts 2019; 9(4): 227 doi: 10.15171/bi.2019.28
|
| 140 |
Sara De Nucci, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Martina Di Chito, Roberta Rinaldi, Vito Giannuzzi, Raffaele Cozzolongo, Giuseppina Piazzolla, Gianluigi Giannelli, Rodolfo Sardone, Giovanni De Pergola. Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1002669
|
| 141 |
Ting-Yu Chen, Ya-Ling Chen, Wan-Chun Chiu, Chiu-Li Yeh, Yu-Tang Tung, Hitoshi Shirakawa, Wei-Tzu Liao, Suh-Ching Yang. Effects of the Water Extract of Fermented Rice Bran on Liver Damage and Intestinal Injury in Aged Rats with High-Fat Diet Feeding. Plants 2022; 11(5): 607 doi: 10.3390/plants11050607
|
| 142 |
Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies. F1000Research 2023; 11: 223 doi: 10.12688/f1000research.109134.2
|
| 143 |
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?. Nutrients 2019; 11(12): 2878 doi: 10.3390/nu11122878
|
| 144 |
Rebecca Sewter, Susan Heaney, Amanda Patterson. Coffee Consumption and the Progression of NAFLD: A Systematic Review. Nutrients 2021; 13(7): 2381 doi: 10.3390/nu13072381
|
| 145 |
Xiaojun Yu, Lin Xie, Yufen Zhou, Xiaoqin Yuan, Yunlin Wu, Ping Chen. Patients with non‑alcoholic fatty liver disease may be a high‑risk group for the development of colorectal polyps: A cross‑sectional study. World Academy of Sciences Journal 2020; 2(6): 1 doi: 10.3892/wasj.2020.71
|
| 146 |
Mélanie Maltais, Diane Brisson, Daniel Gaudet. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia. Journal of Clinical Medicine 2021; 10(4): 669 doi: 10.3390/jcm10040669
|
| 147 |
Suranjan Panigrahi, Ridhi Deo, Edward A. Liechty. A New Machine Learning-Based Complementary Approach for Screening of NAFLD (Hepatic Steatosis). 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021; : 2343 doi: 10.1109/EMBC46164.2021.9629507
|
| 148 |
Hannah Drescher, Sabine Weiskirchen, Ralf Weiskirchen. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Cells 2019; 8(8): 845 doi: 10.3390/cells8080845
|
| 149 |
Patrick T. Campbell, Lisa B. VanWagner, Laura A. Colangelo, Cora E. Lewis, Anne Henkel, Veeral H. Ajmera, Donald M. Lloyd‐Jones, Douglas E. Vaughan, Sadiya S. Khan. Association between plasminogen activator inhibitor‐1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA. Liver International 2020; 40(5): 1111 doi: 10.1111/liv.14417
|
| 150 |
Zoran Gluvic, Ratko Tomasevic, Ksenija Bojovic, Milan Obradovic, Esma R. Isenovic. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice Guidelines. Emergency and Critical Care Medicine 2022; 2(1): 12 doi: 10.1097/EC9.0000000000000016
|
| 151 |
Amélio F. Godoy-Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, João Marcello de Araujo-Neto, Marcello Casaccia Bertoluci. 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01259-2
|
| 152 |
Renata Risi, Rossella Tozzi, Mikiko Watanabe. Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction. Current Opinion in Clinical Nutrition & Metabolic Care 2021; 24(4): 349 doi: 10.1097/MCO.0000000000000762
|
| 153 |
|
| 154 |
Chukwuebuka Joseph Ejiyi, Dongsheng Cai, Makuachukwu B. Ejiyi, Ijeoma A. Chikwendu, Kenneth Coker, Ariyo Oluwasanmi, Oluwatoyosi F. Bamisile, Thomas U. Ejiyi, Zhen Qin. Polynomial-SHAP analysis of liver disease markers for capturing of complex feature interactions in machine learning models. Computers in Biology and Medicine 2024; 182: 109168 doi: 10.1016/j.compbiomed.2024.109168
|
| 155 |
Ahmad Delbari, Shadi Naderyan Feli, Ali Reza Amirabadizadeh, Mahtab Niroomand, Mohammad Bidkhori, Fernando Guerrero-Romero. Prevalence and associated factors of dyslipidemia in elderly people: Results from the Ardakan Cohort Study on Ageing, Iran. PLOS ONE 2024; 19(10): e0306388 doi: 10.1371/journal.pone.0306388
|
| 156 |
Joshua Tseng, Jeremy Korman, Mazen Noureddin, Daniel Shouhed, James P. Miller, Xiaoxi Feng, Miguel Burch. Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH. Obesity Surgery 2022; 32(2): 463 doi: 10.1007/s11695-021-05797-w
|
| 157 |
Dieter Furthner, Daniel Weghuber, Christopher Dalus, Andreas Lukas, Hannah N. Stundner-Ladenhauf, Harald Mangge, Thomas Pixner. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps. Hormone Research in Paediatrics 2022; 95(2): 167 doi: 10.1159/000518595
|
| 158 |
Muhammad Masroor, Zeba Haque. HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters. Journal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2019.00046
|
| 159 |
Sandra A. Soto‐Alarcón, Macarena Ortiz, Paula Orellana, Francisca Echeverría, Andrés Bustamante, Alejandra Espinosa, Paola Illesca, Daniel Gonzalez‐Mañán, Rodrigo Valenzuela, Luis A. Videla. Docosahexaenoic acid and hydroxytyrosol co‐administration fully prevents liver steatosis and related parameters in mice subjected to high‐fat diet: A molecular approach. BioFactors 2019; 45(6): 930 doi: 10.1002/biof.1556
|
| 160 |
Rodrigo M Carrillo-Larco, Wilmer Cristobal Guzman-Vilca, Manuel Castillo-Cara, Claudia Alvizuri-Gómez, Saleh Alqahtani, Vanessa Garcia-Larsen. Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III. BMJ Open 2022; 12(11): e067203 doi: 10.1136/bmjopen-2022-067203
|
| 161 |
Abdulrahman Ismaiel, Stefan-Lucian Popa, Dan L. Dumitrascu, Quirino Lai. Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur”. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8825615
|
| 162 |
Stergios A. Polyzos, Dimitrios G. Goulis, Olga Giouleme, Georgios S. Germanidis, Antonis Goulas. Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease. Current Obesity Reports 2022; 11(3): 166 doi: 10.1007/s13679-022-00474-0
|
| 163 |
Yazhi Wang, Hui Chen. Clinical application of cluster analysis in patients with newly diagnosed type 2 diabetes. Hormones 2024; doi: 10.1007/s42000-024-00593-4
|
| 164 |
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica 2022; 158(11): 550 doi: 10.1016/j.medcli.2021.12.003
|
| 165 |
Rehab F. Abdel-Rahman. Non-alcoholic fatty liver disease. Asian Pacific Journal of Tropical Biomedicine 2022; 12(3): 99 doi: 10.4103/2221-1691.338919
|
| 166 |
Renate L. Hall, Elena S. George, Audrey C. Tierney, Anjana J. Reddy. Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Advances in Nutrition 2023; 14(3): 475 doi: 10.1016/j.advnut.2023.01.001
|
| 167 |
Preethi Chandrasekaran, Ralf Weiskirchen. The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis. International Journal of Molecular Sciences 2024; 25(2): 1109 doi: 10.3390/ijms25021109
|
| 168 |
Ricard Corcelles, Juan S. Barajas-Gamboa, Joana Ferrer-Fàbrega, Matthew Kroh. Cirugía bariátrica en trasplante hepático: tendencias actuales y perspectivas futuras. Cirugía Española 2022; 100(2): 59 doi: 10.1016/j.ciresp.2021.04.025
|
| 169 |
Ricard Corcelles, Juan S. Barajas-Gamboa, Joana Ferrer-Fàbrega, Matthew Kroh. Bariatric surgery in liver transplant: Current trends and future perspectives. Cirugía Española (English Edition) 2022; 100(2): 59 doi: 10.1016/j.cireng.2021.04.021
|
| 170 |
Danyan Ma, Jinyang Zeng, Bingkun Huang, Fangfang Yan, Jiawen Ye, Yun Chen, Xiying Zeng, Xin Zheng, Fangsen Xiao, Mingzhu Lin, Changqin Liu, Zhibin Li. Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02011-0
|
| 171 |
Abdulrahman Ismaiel, Ayman Jaaouani, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis. Biomedicines 2021; 9(12): 1890 doi: 10.3390/biomedicines9121890
|
| 172 |
Xiaoyan Zhang, Jingxin Li, Tiancai Liu, Min Zhao, Baozhu Liang, Hong Chen, Zhen Zhang, Ihtisham Bukhari. Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/4369329
|
| 173 |
Mengqing Zhang, Chengcheng Guo, Zonglin Li, Xiaoling Cai, Xin Wen, Fang Lv, Chu Lin, Linong Ji. Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1α/PPARα and KEAP1/NRF2 Pathways. Pharmaceuticals 2024; 17(10): 1287 doi: 10.3390/ph17101287
|
| 174 |
Ryoko Tajima, Fumiaki Imamura, Takeshi Kimura, Satomi Kobayashi, Katsunori Masuda, Kaoruko Iida. Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adults. Clinical Nutrition 2020; 39(5): 1580 doi: 10.1016/j.clnu.2019.07.001
|
| 175 |
Anton Gillessen, Francesco Angelico, Jun Chen, Lungen Lu, Maria Isabel Lucena, Qingchun Fu, Qing Xie, Raul J. Andrade, Wen Xie, Xiaoyuan Xu, Yanyan Yu, Yi-min Mao, Yuemin Nan. Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations. Gastro Hep Advances 2022; 1(5): 882 doi: 10.1016/j.gastha.2022.05.006
|
| 176 |
Jai Kumar, Sana Mohsin, Misha Hasan, Abdur Raheem Bilal, Kumail Mustafa Ali, Ahmed Umer, Dua Zehra Mohammad Hadi, Sanjna Nandlal, Sarwan Kumar. Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(1): 102261 doi: 10.1016/j.clinre.2023.102261
|
| 177 |
Jane Ha, Sun Young Yim, Raffi Karagozian. Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2023; 21(10): 2496 doi: 10.1016/j.cgh.2022.11.019
|
| 178 |
Kelly Casler, Amanda Chaney. Cirrhosis. Nursing 2021; 51(2): 24 doi: 10.1097/01.NURSE.0000731828.24893.bb
|
| 179 |
Valentin Metzner, Gloria Herzog, Tobias Heckel, Thorsten Bischler, Julia Hasinger, Christoph Otto, Martin Fassnacht, Andreas Geier, Florian Seyfried, Ulrich Dischinger. Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements. Journal of Clinical Medicine 2022; 11(3): 753 doi: 10.3390/jcm11030753
|
| 180 |
Sze Zee Lim, Kee Huat Chuah, Ruveena Bhavani Rajaram, Khoo Stanley, Shahreedhan Shahrani, Wah Kheong Chan, Shiaw Hooi Ho, Ida Normiha Hilmi, Khean Lee Goh, Sanjiv Mahadeva. Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single‐center observational study. Journal of Gastroenterology and Hepatology 2022; 37(9): 1732 doi: 10.1111/jgh.15905
|
| 181 |
Stephen D. H. Malnick, Pavel Alin, Marina Somin, Manuela G. Neuman. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. International Journal of Molecular Sciences 2022; 23(24): 16226 doi: 10.3390/ijms232416226
|
| 182 |
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
|
| 183 |
Tiantian Song, Shuchun Chen, Hang Zhao, Fei Wang, Huan Song, Dongliang Tian, Qiwen Yang, Licui Qi. Meta‐analysis of the effect of sodium–glucose cotransporter 2 inhibitors on hepatic fibrosis in patients with type 2 diabetes mellitus complicated with non‐alcoholic fatty liver disease. Hepatology Research 2021; 51(6): 641 doi: 10.1111/hepr.13645
|
| 184 |
Keyvan Hejazi, Daniel Hackett. Effect of Exercise on Liver Function and Insulin Resistance Markers in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine 2023; 12(8): 3011 doi: 10.3390/jcm12083011
|
| 185 |
|
| 186 |
Hannah Collins, Grant Beban, John Windsor, Rishi Ram, David Orr, Nicholas Evennett, Benjamin Loveday. Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting. Obesity Surgery 2020; 30(1): 313 doi: 10.1007/s11695-019-04161-3
|
| 187 |
Norbert Stefan, Marek Hartleb, Branko Popovic, Rafael Varona. Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial. Trials 2024; 25(1) doi: 10.1186/s13063-024-08208-4
|
| 188 |
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans‐Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon‐Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterology Journal 2022; 10(7): 663 doi: 10.1002/ueg2.12280
|
| 189 |
Vahibe Uluçay Kestane, Murat Baş. Efficacy of the Mediterranean Diet Containing Different Macronutrients on Non-Alcoholic Fatty Liver Disease. Nutrients 2024; 16(16): 2699 doi: 10.3390/nu16162699
|
| 190 |
M. V. Kruchinina, M. V. Parulikova, A. V. Belkovets, K. Yu. Nikolaev, A. K. Ovsyannikova. Features of the fatty acid profile of erythrocyte membranes in patients with fatty liver disease of alcoholic genesis. Meditsinskiy sovet = Medical Council 2023; (18): 84 doi: 10.21518/ms2023-391
|
| 191 |
Dou-Dou Li, Jia-Min Ma, Ming-Jing Li, Lu-Lu Gao, Yan-Na Fan, Yan-Nan Zhang, Xiu-Juan Tao, Jian-Jun Yang. Supplementation of Lycium barbarum Polysaccharide Combined with Aerobic Exercise Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis via AMPK/PPARα/PGC-1α Pathway. Nutrients 2022; 14(15): 3247 doi: 10.3390/nu14153247
|
| 192 |
D. V. Garbuzenko. Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 31(5): 16 doi: 10.22416/1382-4376-2021-31-5-16-24
|
| 193 |
Azadeh Hojreh, Julia Lischka, Dietmar Tamandl, Dariga Ramazanova, Amra Mulabdic, Susanne Greber-Platzer, Ahmed Ba-Ssalamah. Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric Obesity. Nutrients 2023; 15(3): 558 doi: 10.3390/nu15030558
|
| 194 |
Benedikt Kaufmann, Nick Seyfried, Daniel Hartmann, Phillipp Hartmann. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 325(1): G42 doi: 10.1152/ajpgi.00017.2023
|
| 195 |
Danqing Hu, Peng Wang, Xiaojing Wang, Xue Hu, Da Huang, Weiming Yan, Dong Xi, Meifang Han, Qin Ning, Hongwu Wang. Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD. Journal of the Formosan Medical Association 2024; 123(7): 773 doi: 10.1016/j.jfma.2023.12.001
|
| 196 |
Daniel Faurholt-Jepsen, Henrik Friis, David L. Mwaniki, Michael K. Boit, Lydia U. Kaduka, Inge Tetens, Dirk L. Christensen, Giacomo Pucci. Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults. PLOS ONE 2021; 16(2): e0247600 doi: 10.1371/journal.pone.0247600
|
| 197 |
Saber Ghiassi, Maher El Chaar, Essa M. Aleassa, Fady Moustarah, Sofiane El Djouzi, T. Javier Birriel, Ann M. Rogers. ASMBS position statement on the relationship between obesity and cancer, and the role of bariatric surgery: risk, timing of treatment, effects on disease biology, and qualification for surgery. Surgery for Obesity and Related Diseases 2020; 16(6): 713 doi: 10.1016/j.soard.2020.03.019
|
| 198 |
Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(14): 3029 doi: 10.3390/jcm10143029
|
| 199 |
Hao Han, Yan Guo, Xiaoyu Li, Dongxing Shi, Tingli Xue, Linqi Wang, Yanyan Li, Mingming Zheng. Plant Sterol Ester of α-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial Biogenesis. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8294141
|
| 200 |
Mithun Sharma, Madhumita Premkumar, Anand V Kulkarni, Pramod Kumar, D Nageshwar Reddy, Nagaraja Padaki Rao. Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail. Journal of Clinical and Translational Hepatology 2020; 0(000): 1 doi: 10.14218/JCTH.2020.00055
|
| 201 |
Anouk Charlot, Joffrey Zoll. Beneficial Effects of the Ketogenic Diet in Metabolic Syndrome: A Systematic Review. Diabetology 2022; 3(2): 292 doi: 10.3390/diabetology3020020
|
| 202 |
Eduardo Lemos De Souza Bastos, Almino Ramos Cardoso. The Perfect Sleeve Gastrectomy. 2020; : 19 doi: 10.1007/978-3-030-28936-2_3
|
| 203 |
Wangya Jia, Keke Wang, Shaobo Zhang, Wenxu Lu, Ao Du, Jian Li, Lili Ji, Hong Xu. Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease. Phytomedicine 2022; 104: 154326 doi: 10.1016/j.phymed.2022.154326
|
| 204 |
MoezAlIslam Faris, Haitham Jahrami, Dana Abdelrahim, Nicola Bragazzi, Ahmed BaHammam. The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression. Diabetes Research and Clinical Practice 2021; 178: 108951 doi: 10.1016/j.diabres.2021.108951
|
| 205 |
Kay Craven, Donna Clement, Caroline T. Brewster, Jamie Messenger, Kathryn M. Kolasa. Non-Alcoholic Fatty Liver Disease (NAFLD) and Nutrition. Nutrition Today 2021; 56(6): 296 doi: 10.1097/NT.0000000000000514
|
| 206 |
Julia R. Gips, Lisa Yanek, Jiajun Wu, James P. Hamilton, Tinsay A. Woreta, Jeanne M. Clark. Clinical cohort of nonalcoholic fatty liver disease in a primary care setting. Journal of Family Medicine and Primary Care 2024; 13(8): 2958 doi: 10.4103/jfmpc.jfmpc_1769_23
|
| 207 |
Elena-Daniela Grigorescu, Mariana Floria, Cristina Mihaela Lăcătușu, Bogdan Mircea-Mihai, Ioana Creţu, Alina Delia Popa, Alina Onofriescu, Irina M. Jaba, Victoriţa Șorodoc, Alexandr Ceasovschih, Laurenţiu Șorodoc. The Relationship between Hepatic Steatosis, inflammation and insulin Resistance in type 2 Diabetes with Metabolic Imbalance. Internal Medicine 2019; 16(4): 13 doi: 10.2478/inmed-2019-0073
|
| 208 |
Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shuixian Du, Quanjiang Dong, Yongning Xin, Shiying Xuan. Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review). Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7781
|
| 209 |
Stefano Ciardullo, Gianluca Perseghin. From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction. Metabolism and Target Organ Damage 2024; doi: 10.20517/mtod.2024.39
|
| 210 |
Lorena Fecury Tavares, Mariana Rosa Bernardo, Kalil Orleans Silveira Pinho, Ana Paula Santos Oliveira Brito, Rodrigo Bona Maneschy, Hamilton Cezar Rocha de Garcia. Doença Hepática Gordurosa Não Alcoólica - Diagnóstico e tratamento. Pará Research Medical Journal 2022; 3(2): 1 doi: 10.4322/prmj.2019.011
|
| 211 |
Abdulrahman Ismaiel, Blal El Hosiny, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Cristina Sorina Catana, Dan L. Dumitrascu. Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102160 doi: 10.1016/j.clinre.2023.102160
|
| 212 |
Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, Karin Hepp Schwambach, Cristiane Valle Tovo, Carine Raquel Blatt. Drug-induced liver injury and COVID-19: A review for clinical practice. World Journal of Hepatology 2021; 13(9): 1143-1153 doi: 10.4254/wjh.v13.i9.1143
|
| 213 |
Meng-Hsun Yu, Tung-Wei Hung, Chi-Chih Wang, Sheng-Wen Wu, Tzu-Wei Yang, Ching-Yu Yang, Tsui-Hwa Tseng, Chau-Jong Wang. Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro. International Journal of Molecular Sciences 2021; 22(23): 13163 doi: 10.3390/ijms222313163
|
| 214 |
Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J. Sanyal, Anne-Sophie Sejling, Stephen A. Harrison. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. New England Journal of Medicine 2021; 384(12): 1113 doi: 10.1056/NEJMoa2028395
|
| 215 |
Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Angiology 2022; 73(8): 701 doi: 10.1177/00033197221091317
|
| 216 |
Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study. European Journal of Nutrition 2021; 60(6): 3043 doi: 10.1007/s00394-020-02476-x
|
| 217 |
Satu Korpimäki, Suvi P Rovio, Markus Juonala, Nina Hutri-Kähönen, Terho Lehtimäki, Tomi P Laitinen, Päivi Tossavainen, Eero Jokinen, Britt-Marie Loo, Satu Männistö, Tuija Tammelin, Atte Haarala, Heikki Aatola, Gaber Komar, Jorma Viikari, Olli Raitakari, Mika Kähönen, Katja Pahkala. Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among Finns. The Journal of Clinical Endocrinology & Metabolism 2023; 109(1): e291 doi: 10.1210/clinem/dgad418
|
| 218 |
Marc-Olivier Deguise, Chantal Pileggi, Yves De Repentigny, Ariane Beauvais, Alexandra Tierney, Lucia Chehade, Jean Michaud, Maica Llavero-Hurtado, Douglas Lamont, Abdelmadjid Atrih, Thomas M. Wishart, Thomas H. Gillingwater, Bernard L. Schneider, Mary-Ellen Harper, Simon H. Parson, Rashmi Kothary. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(1): 354 doi: 10.1016/j.jcmgh.2021.01.019
|
| 219 |
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1167 doi: 10.2147/DMSO.S300051
|
| 220 |
Yongin Cho, Yong-ho Lee. State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis. Endocrinology and Metabolism 2022; 37(1): 38 doi: 10.3803/EnM.2022.102
|
| 221 |
Elizabeth R. M. Zunica, Elizabeth C. Heintz, Christopher L. Axelrod, John P. Kirwan. Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers 2022; 14(16): 4051 doi: 10.3390/cancers14164051
|
| 222 |
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Review of Gastroenterology & Hepatology 2019; 13(7): 667 doi: 10.1080/17474124.2019.1621164
|
| 223 |
Chayanis Kositamongkol, Thammanard Charernboon, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Chonticha Auesomwang, Tullaya Sitasuwan, Phunchai Charatcharoenwitthaya, Pochamana Phisalprapa. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome. Medicine 2021; 100(44): e27640 doi: 10.1097/MD.0000000000027640
|
| 224 |
Li‐Wei Chen, Mi‐Sio Huang, Yu‐Chiau Shyu, Rong‐Nan Chien. Gamma‐glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community‐based cross‐sectional study. The Kaohsiung Journal of Medical Sciences 2021; 37(9): 819 doi: 10.1002/kjm2.12395
|
| 225 |
Zhen-Shu Liu, Pei-Lin Li, Yu-We Ku, Po-Wen Chen. Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice. Microorganisms 2022; 10(11): 2215 doi: 10.3390/microorganisms10112215
|
| 226 |
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar. A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals. Journal of Gastroenterology and Hepatology 2021; 36(6): 1497 doi: 10.1111/jgh.15353
|
| 227 |
Shirley Yuk-Wah Liu, Vincent Wai-Sun Wong, Simon Kin-Hung Wong, Grace Lai-Hung Wong, Carol Man-sze Lai, Candice Chuen-Hing Lam, Sally She-Ting Shu, Henry Lik-Yuen Chan, Enders Kwok-Wai Ng. A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83782-0
|
| 228 |
Allison M. Carroll, Yaron Rotman. Nutrition Literacy Is Not Sufficient to Induce Needed Dietary Changes in Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology 2023; 118(8): 1381 doi: 10.14309/ajg.0000000000002182
|
| 229 |
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena Shirokova, Kirill M Starostin. Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. BMJ Open Gastroenterology 2019; 6(1): e000307 doi: 10.1136/bmjgast-2019-000307
|
| 230 |
Hasen A. Al-ghamdi, Fayza F. Al Fayez, Abdulhadi I. Bima, Taghreed M. Khawaji, Ayman Z. Elsamanoudy. Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation. Journal of Clinical and Experimental Hepatology 2021; 11(2): 219 doi: 10.1016/j.jceh.2020.07.003
|
| 231 |
Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, Benedicto Crespo Facorro. Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019; 95: 109677 doi: 10.1016/j.pnpbp.2019.109677
|
| 232 |
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
|
| 233 |
Xiongfeng Pan, Shi Wu Wen, Atipatsa C. Kaminga, Aizhong Liu. Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65051-8
|
| 234 |
Lvying Wu, Lei Xing, Yake Zou, Zichen Wang, Yuanyuan Li, Lei Zhang, Su Guan. UPLC-QTOF-MS Based Comparison of Rotundic Acid Metabolic Profiles in Normal and NAFLD Rats. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4005127
|
| 235 |
Priyanka Bhandari, Amit Sapra, Mohitkumar S Ajmeri, Christine E Albers, Devanshika Sapra. Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?. Cureus 2022; doi: 10.7759/cureus.23806
|
| 236 |
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, Joseph M Pappachan. Management of metabolic-associated fatty liver disease: The diabetology perspective. World Journal of Gastroenterology 2023; 29(1): 126-143 doi: 10.3748/wjg.v29.i1.126
|
| 237 |
Amir Mari, Tawfik Khoury, Helal Said Ahmad, Fadi Abu Baker, Anas Kadah, Wisam Sbeit, Rinaldo Pellicano, Mahmud Mahamid. The association between non-alcoholic fatty liver disease and valvular heart disease. Minerva Cardioangiologica 2020; 68(1) doi: 10.23736/S0026-4725.19.05087-4
|
| 238 |
Mustafa Al-Karaghouli, Sonia Fuentes, Tracy Davyduke, Mang Ma, Juan G Abraldes. Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD. BMJ Open Gastroenterology 2022; 9(1): e000798 doi: 10.1136/bmjgast-2021-000798
|
| 239 |
Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina. Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. SAGE Open Medicine 2020; 8 doi: 10.1177/2050312120933804
|
| 240 |
Anna Laitakari, Joona Tapio, Kari A. Mäkelä, Karl-Heinz Herzig, Franziska Dengler, Helena Gylling, Gail Walkinshaw, Johanna Myllyharju, Elitsa Y. Dimova, Raisa Serpi, Peppi Koivunen. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. Journal of Molecular Medicine 2020; 98(5): 719 doi: 10.1007/s00109-020-01903-0
|
| 241 |
Philip Berry, Sreelakshmi Kotha. The Challenging Ethical Landscape of Non-alcoholic Fatty Liver Disease. EMJ Hepatology 2022; doi: 10.33590/emjhepatol/21-00217
|
| 242 |
Macarena Ortiz, Sandra A. Soto-Alarcón, Paula Orellana, Alejandra Espinosa, Cristian Campos, Sandra López-Arana, Miguel A. Rincón, Paola Illesca, Rodrigo Valenzuela, Luis A. Videla. Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration. Digestive and Liver Disease 2020; 52(8): 895 doi: 10.1016/j.dld.2020.04.019
|
| 243 |
Mohammad H. Jamal, Rawan El-Abd. Laparoscopic Sleeve Gastrectomy. 2021; : 115 doi: 10.1007/978-3-030-57373-7_15
|
| 244 |
Nuria Perez-Diaz-del-Campo, Jose I. Riezu-Boj, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Fermín I. Milagro, Josep A. Tur, Itziar Abete, M. Angeles Zulet, J. Alfredo Martinez. Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study. Diagnostics 2021; 11(6): 1083 doi: 10.3390/diagnostics11061083
|
| 245 |
Shengnan Tang, Jin Wu, Shanshan Xu, Qi Li, Jian He. Clinical-radiomic analysis for non-invasive prediction of liver steatosis on non-contrast CT: A pilot study. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1071085
|
| 246 |
Ana J. F. C. Aguiar, Jaluza L. C. de Queiroz, Pedro P. A. Santos, Christina S. Camillo, Alexandre C. Serquiz, Izael S. Costa, Gerciane S. Oliveira, Ana F. T. Gomes, Lídia L. R. Matias, Rafael O. A. Costa, Thaís S. Passos, Ana H. A. Morais. Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study. International Journal of Molecular Sciences 2021; 22(18): 9968 doi: 10.3390/ijms22189968
|
| 247 |
Caroline Chong Nguyen, Denis Duboc, Dominique Rainteau, Harry Sokol, Lydie Humbert, Philippe Seksik, Adèle Bellino, Hendy Abdoul, Naïm Bouazza, Jean-Marc Treluyer, Malika Saadi, Karim Wahbi, Heithem Soliman, Benoit Coffin, André Bado, Maude Le Gall, Olivier Varenne, Henri Duboc. Circulating bile acids concentration is predictive of coronary artery disease in human. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02144-y
|
| 248 |
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery. Expert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
|
| 249 |
Jennifer Linge, Mattias Ekstedt, Olof Dahlqvist Leinhard. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Reports 2021; 3(1): 100197 doi: 10.1016/j.jhepr.2020.100197
|
| 250 |
Chutian Wu, Yun Zhou, Min Wang, Guolin Dai, Xiongxiu Liu, Leizhen Lai, Shaohui Tang. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.772487
|
| 251 |
Hyun-Ji Kim, Eun Bok Baek, Ji-Hee Hwang, Minyoung Lim, Won Hoon Jung, Myung Ae Bae, Hwa-Young Son, Jae-Woo Cho. Application of convolutional neural network for analyzing hepatic fibrosis in mice. Journal of Toxicologic Pathology 2023; 36(1): 21 doi: 10.1293/tox.2022-0066
|
| 252 |
Md. Jahangir Alam, Sanjay K. Banerjee. Biochemistry of Cardiovascular Dysfunction in Obesity. 2020; : 15 doi: 10.1007/978-3-030-47336-5_2
|
| 253 |
Fátima Higuera-de-la-Tijera, Jacqueline Córdova-Gallardo, Elizabeth Buganza-Torio, Beatriz Barranco-Fragoso, Aldo Torre, Sara Parraguirre-Martínez, Martin Edgardo Rojano-Rodríguez, Gabriel Quintero-Bustos, Graciela Castro-Narro, Carlos Moctezuma-Velazquez. Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value. Digestive Diseases and Sciences 2021; 66(12): 4501 doi: 10.1007/s10620-020-06821-2
|
| 254 |
Silvia Ferri, Bernardo Stefanini, Lorenzo Mulazzani, Margherita Alvisi, Francesco Tovoli, Simona Leoni, Luca Muratori, Tommaso Lotti, Alessandro Granito, Luigi Bolondi, Fabio Piscaglia. Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients 2022; 14(12): 2493 doi: 10.3390/nu14122493
|
| 255 |
Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International 2020; 14(6): 889 doi: 10.1007/s12072-020-10094-2
|
| 256 |
Iresha Sandamali Koralegedara, Janith Niwanthaka Warnasekara, Ashani Rathnayake, Korale Gedara Dayaratne, Suneth Buddhika Agampodi. Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy. BMJ Open Gastroenterology 2022; 9(1): e000913 doi: 10.1136/bmjgast-2022-000913
|
| 257 |
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
|
| 258 |
Atilla BEKTAS, Meltem ULUSOY, Kemal DAĞALP. Ursodeoksikolik Asit, Diyabetik Olmayan, Alkol Dışı Karaciğer Yağlanması Tedavisinde Yer Almalı Mı?. Konuralp Tıp Dergisi 2020; 12(1): 44 doi: 10.18521/ktd.527978
|
| 259 |
Wah‐Kheong Chan, Soek‐Siam Tan, Siew‐Pheng Chan, Yeong‐Yeh Lee, Hoi‐Poh Tee, Sanjiv Mahadeva, Khean‐Lee Goh, Anis Safura Ramli, Feisul Mustapha, Nik Ritza Kosai, Raja Affendi Raja Ali. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease. Journal of Gastroenterology and Hepatology 2022; 37(5): 795 doi: 10.1111/jgh.15787
|
| 260 |
Joscha Vonderlin, Triantafyllos Chavakis, Michael Sieweke, Frank Tacke. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis. Cellular and Molecular Gastroenterology and Hepatology 2023; 15(6): 1311 doi: 10.1016/j.jcmgh.2023.03.002
|
| 261 |
A.J. Scheen. Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications. Diabetes & Metabolism 2019; 45(3): 213 doi: 10.1016/j.diabet.2019.01.008
|
| 262 |
Luisa Barana, Georgia Colleluori, Maria Teresa Sulpizi, Kathleen Ortenzi, Luca Farano, Carmine Giuseppe Fanelli, Riccardo Calafiore, Laura Dalla Ragione, Simone Pampanelli. Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating. Journal of Diabetes & Metabolic Disorders 2022; 21(2): 1883 doi: 10.1007/s40200-022-01085-1
|
| 263 |
Yunpeng Gu, Wei Zhang, Yanli Hu, Yutong Chen, Junping Shi. Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studies. Journal of Affective Disorders 2022; 301: 8 doi: 10.1016/j.jad.2021.12.128
|
| 264 |
Gerardo Sarno, Luigi Schiavo, Pietro Calabrese, Ludwig Álvarez Córdova, Evelyn Frias-Toral, Gabriela Cucalón, Eloisa Garcia-Velasquez, Vanessa Fuchs-Tarlovsky, Vincenzo Pilone. The Impact of Bariatric-Surgery-Induced Weight Loss on Patients Undergoing Liver Transplant: A Focus on Metabolism, Pathophysiological Changes, and Outcome in Obese Patients Suffering NAFLD-Related Cirrhosis. Journal of Clinical Medicine 2022; 11(18): 5293 doi: 10.3390/jcm11185293
|
| 265 |
Kenneth W. Chow, Pragyat Futela, Aryan Saharan, Sammy Saab. Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(5): 783 doi: 10.1016/j.jceh.2023.01.016
|
| 266 |
Tae Jung Oh, Kyuho Kim, Jae Hoon Moon, Sung Hee Choi, Nam H Cho, Hak Chul Jang. Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort Study. Journal of the Endocrine Society 2021; 5(10) doi: 10.1210/jendso/bvab123
|
| 267 |
Stephen A. Harrison, Vlad Ratziu, Jeremy Magnanensi, Yacine Hajji, Sylvie Deledicque, Zouher Majd, Christian Rosenquist, Dean W. Hum, Bart Staels, Quentin M. Anstee, Arun J. Sanyal. NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study. Journal of Hepatology 2023; 79(3): 758 doi: 10.1016/j.jhep.2023.04.031
|
| 268 |
Giulia Besutti, Lisa Bonilauri, Elisa Manicardi, Francesco Venturelli, Efrem Bonelli, Filippo Monelli, Valeria Manicardi, Luca Valenti, Guido Ligabue, Susanna Schianchi, Marco Massari, Nicoletta Riva, Elisabetta Froio, Elena Tagliavini, Pierpaolo Pattacini, Paolo Giorgi Rossi. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study. Diabetes Research and Clinical Practice 2021; 177: 108882 doi: 10.1016/j.diabres.2021.108882
|
| 269 |
М. В. Кручинина, М. В. Паруликова, Н. Е. Першина, Э. В. Кручинина. Жирные кислоты мембран эритроцитов как биомаркеры неалкогольной жировой болезни печени у мужчин. Ateroscleroz 2023; 18(4): 362 doi: 10.52727/2078-256X-2022-18-4-362-380
|
| 270 |
Maria Lilibeth Manzanilla Valdez, Maira Rubi Segura Campos. Renal and Hepatic Disease:Cnidoscolus aconitifoliusas Diet Therapy Proposal for Prevention and Treatment. Journal of the American College of Nutrition 2021; 40(7): 646 doi: 10.1080/07315724.2020.1810171
|
| 271 |
Ron S. Newfield, Carrie L. Graves, Robert O. Newbury, Jeffrey B. Schwimmer, James A. Proudfoot, Daphne S. Say, Ariel E. Feldstein. Non‐alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects. Pediatric Diabetes 2018; doi: 10.1111/pedi.12798
|
| 272 |
Stergios A. Polyzos, Eun Seok Kang, Chrysoula Boutari, Eun-Jung Rhee, Christos S. Mantzoros. Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. Metabolism 2020; 111: 154203 doi: 10.1016/j.metabol.2020.154203
|
| 273 |
Jiajun Qiu, Maobin Kuang, Shiming He, Changhui Yu, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1302322
|
| 274 |
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism 2019; 92: 82 doi: 10.1016/j.metabol.2018.11.014
|
| 275 |
Taisiia Turankova, Oleg Blyuss, Alexey Brazhnikov, Andrey Svistunov, Kurinchi Selvan Gurusamy, Chavdar S Pavlov. Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD013670
|
| 276 |
Qiu-Xuan Li, Han Gao, Yue-Xin Guo, Bo-Ya Wang, Rong-xuan Hua, Lei Gao, Hong-Wei Shang, Xin Lu, Jing-Dong Xu. GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.721198
|
| 277 |
Ralitsa Robeva, Dušan Mladenović, Milena Vesković, Dragan Hrnčić, Jelica Bjekić-Macut, Olivera Stanojlović, Sarantis Livadas, Bulent O. Yildiz, Djuro Macut. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. Maturitas 2021; 151: 22 doi: 10.1016/j.maturitas.2021.06.012
|
| 278 |
Xueqi Li, Xianjue Huang, Guangwen Cheng, Jing Liang, Luping Qiu, Jubo Zhang, Qiyuan Yao, Hong Ding. Optimizing the number of valid measurements for the attenuation coefficient to assess hepatic steatosis in MAFLD patients: A study of 139 patients who underwent liver biopsy. Ultraschall in der Medizin - European Journal of Ultrasound 2024; 45(04): 395 doi: 10.1055/a-2178-5022
|
| 279 |
Gianni BELCARO, David M. COX, M. Rosaria CESARONE, Giuseppe GIZZI, Luciano PELLEGRINI, Claudia SCIPIONE, Valeria SCIPIONE, Mark DUGALL, Shu HU, Marcello CORSI, Beatrice FERAGALLI, Roberto COTELLESE. Effects of Robuvit® on the progression of non-alcoholic fatty liver disease. Minerva Gastroenterology 2022; 68(4) doi: 10.23736/S2724-5985.22.03201-6
|
| 280 |
Liyuan Hao, Shenghao Li, Guo Chen, Xiaoyu Hu. Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural product. Chemical Biology & Drug Design 2024; 103(2) doi: 10.1111/cbdd.14461
|
| 281 |
Simona Cernea, Itamar Raz. NAFLDin type 2 diabetes mellitus: Still many challenging questions. Diabetes/Metabolism Research and Reviews 2021; 37(2) doi: 10.1002/dmrr.3386
|
| 282 |
Manal H. El-Sayed, Rasha A. Thabet, Mohamed T. Hamza, Muhammad S. Hussein, Maha M. El Saeed. Liver disease in children and adolescents with type 1 diabetes mellitus: A link between glycemic control and hepatopathy. Diabetes Research and Clinical Practice 2020; 170: 108458 doi: 10.1016/j.diabres.2020.108458
|
| 283 |
Yi-Ning Dai, Cheng-Fu Xu, Hong-Ying Pan, Hai-Jun Huang, Mei-Juan Chen, You-Ming Li, Chao-Hui Yu. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease. World Journal of Clinical Cases 2022; 10(13): 4097-4109 doi: 10.12998/wjcc.v10.i13.4097
|
| 284 |
Begoña Lavin, Thomas R. Eykyn, Alkystis Phinikaridou, Aline Xavier, Shravan Kumar, Xabier Buqué, Patricia Aspichueta, Carlos Sing‐Long, Marco Arrese, René M. Botnar, Marcelo E. Andia. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. NMR in Biomedicine 2023; 36(8) doi: 10.1002/nbm.4932
|
| 285 |
Maya Margalit, Hanny Yeshua, Neta Gotlieb, Shira Zelber-Sagi. NAFLD and NASH. 2020; : 11 doi: 10.1007/978-3-030-37173-9_2
|
| 286 |
Élise Vuille-Lessard, Naomi Lange, Carlotta Riebensahm, Jean-François Dufour, Annalisa Berzigotti. Dietary Interventions in Liver Diseases: Focus on MAFLD and Cirrhosis. Current Hepatology Reports 2021; 20(2): 61 doi: 10.1007/s11901-021-00563-z
|
| 287 |
Weijie Lin, Zhengrong Liu, Ling Li, Zhiling Zhou, Shiyu Ma, Fazhong He. Effects of Shugan Quzhi Capsule in treating different metabolic diseases based on network pharmacology and molecular docking. 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2021; : 3832 doi: 10.1109/BIBM52615.2021.9669290
|
| 288 |
Juan Li, Mingxing Yin, Maoxian Tian, Jianguo Fang, Hanlin Xu. Stiff-Soft Hybrid Biomimetic Nano-Emulsion for Targeted Liver Delivery and Treatment of Early Nonalcoholic Fatty Liver Disease. Pharmaceutics 2024; 16(10): 1303 doi: 10.3390/pharmaceutics16101303
|
| 289 |
Yan Sun, Nie Zhang, Yun-Long Ding, Li-Jiang Yu, Jun Cai, De Ma, Wu Yang, Wang-Kun Lu, Jia-Li Niu. Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control study. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1063-y
|
| 290 |
Samy A. Azer, Rana Hasanato. Use of bile acids as potential markers of liver dysfunction in humans. Medicine 2021; 100(41): e27464 doi: 10.1097/MD.0000000000027464
|
| 291 |
Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo, Francisco Javier Bosques-Padilla. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World Journal of Hepatology 2021; 13(11): 1494-1511 doi: 10.4254/wjh.v13.i11.1494
|
| 292 |
Amedeo Lonardo. Metabolomic signature: one step forward in the process of obtaining NAFLD patients’ metabolic identity card. The American Journal of Clinical Nutrition 2022; 115(3): 603 doi: 10.1093/ajcn/nqab399
|
| 293 |
Joanna Michałowska, Ewa Miller-Kasprzak, Paweł Bogdański. Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective. Nutrients 2021; 13(2): 351 doi: 10.3390/nu13020351
|
| 294 |
Livhuwani P. Nendouvhada, Nicole R. S. Sibuyi, Adewale O. Fadaka, Samantha Meyer, Abram M. Madiehe, Mervin Meyer, Kwazikwakhe B. Gabuza. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2024; 25(11): 5571 doi: 10.3390/ijms25115571
|
| 295 |
Amani Al-Shargi, Amal A. El Kholy, Abdulmoneim Adel, Mohamed Hassany, Sara M. Shaheen. Allopurinol versus Febuxostat: A New Approach for the Management of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomedicines 2023; 11(11): 3074 doi: 10.3390/biomedicines11113074
|
| 296 |
Sara De Nucci, Caterina Bonfiglio, Rosanna Donvito, Martina Di Chito, Nicole Cerabino, Roberta Rinaldi, Annamaria Sila, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Elsa Lanzilotta, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity. Nutrients 2023; 15(20): 4468 doi: 10.3390/nu15204468
|
| 297 |
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
|
| 298 |
Peizuo Zhao, Weidong Yang, Huiyu Xiao, Shuaishuai Zhang, Chuanzhou Gao, Hua Piao, Lihong Liu, Shuzhuang Li. Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53644-6
|
| 299 |
Muhammad Usman, Nabiyah Bakhtawar. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials . Cureus 2020; doi: 10.7759/cureus.9018
|
| 300 |
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
|
| 301 |
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2022; 41(10): 2364 doi: 10.1016/j.clnu.2022.07.003
|
| 302 |
Hao Han, Tingli Xue, Jie Li, Yan Guo, Xiaoyu Li, Linqi Wang, Liyuan Pei, Mingming Zheng. Plant sterol ester of α-linolenic acid improved non-alcoholic fatty liver disease by attenuating endoplasmic reticulum stress-triggered apoptosis via activation of the AMPK. The Journal of Nutritional Biochemistry 2022; 107: 109072 doi: 10.1016/j.jnutbio.2022.109072
|
| 303 |
Guoyan Jiang, Chunhong Sun, Xiaodong Wang, Jie Mei, Chen Li, Honghong Zhan, Yixuan Liao, Yongjun Zhu, Jingxin Mao. Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification. Bioengineered 2022; 13(3): 5216 doi: 10.1080/21655979.2022.2037374
|
| 304 |
Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes. Biomedicines 2023; 11(10): 2611 doi: 10.3390/biomedicines11102611
|
| 305 |
Julia Teck. Diabetes-Associated Comorbidities. Primary Care: Clinics in Office Practice 2022; 49(2): 275 doi: 10.1016/j.pop.2021.11.004
|
| 306 |
Hüseyin Vural, Ferah Armutcu, Omer Akyol, Ralf Weiskirchen. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clinica Chimica Acta 2021; 523: 374 doi: 10.1016/j.cca.2021.10.018
|
| 307 |
Yahya Pasdar, Farhad Oubari, Mahin Nikougoftar Zarif, Mehrnaz Abbasi, Azizollah Pourmahmoudi, Mahboobe Hosseinikia. Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot Study. Clinical Nutrition Research 2020; 9(1): 11 doi: 10.7762/cnr.2020.9.1.11
|
| 308 |
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
|
| 309 |
Ji Won Kwak, Yong Jae Lee, Byoungjin Park, Dong Hyuk Jung. Combined effect of serum carcinoembryonic antigen and hepatic steatosis on new-onset ischemic heart disease among middle-aged and older Korean adults: a cohort study. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1275450
|
| 310 |
Rita Basu, Mazen Noureddin, Jeanne M. Clark. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers. Mayo Clinic Proceedings 2022; 97(9): 1700 doi: 10.1016/j.mayocp.2022.04.005
|
| 311 |
Rohitash Jamwal, Benjamin J. Barlock. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes. Pharmaceuticals 2020; 13(9): 222 doi: 10.3390/ph13090222
|
| 312 |
Ming Li, Qian Wang, Yong Li, Shengtian Cao, Yingjun Zhang, Zhongqing Wang, Guozhu Liu, Jing Li, Baohua Gu. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges. Pharmacology & Therapeutics 2020; 212: 107539 doi: 10.1016/j.pharmthera.2020.107539
|
| 313 |
L.V. Zhuravlyova, O.V. Elhaj. THE ROLE OF RESISTIN IN THE PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE. Inter Collegas 2021; 8(3): 157 doi: 10.35339/ic.8.3.157-162
|
| 314 |
Carlos Benítez, Juan Pablo Arab, Francisco Barrera, Jesus M. Banales, Marco Arrese. NAFLD and NASH. 2020; : 225 doi: 10.1007/978-3-030-37173-9_13
|
| 315 |
D. Yu. Venidiktova, A. V. Borsukov. Non-drug treatment of non-alcoholic fatty liver disease: evaluation of effectiveness with ultrasound steatometry. Medical alphabet 2020; (10): 38 doi: 10.33667/2078-5631-2020-10-38-42
|
| 316 |
Mingshan Guo, Qianyu Pan, Xiaojin Shi, W. Du, S. Grasso. The Comparison and Contrast on NAFLD between the East and the West: Metabolic Mechanism, Dietary Habits, and Policies. E3S Web of Conferences 2021; 308: 02021 doi: 10.1051/e3sconf/202130802021
|
| 317 |
Ysabel C. Ilagan-Ying, Bubu A. Banini, Albert Do, Robert Lam, Joseph K. Lim. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice. Current Gastroenterology Reports 2023; 25(10): 213 doi: 10.1007/s11894-023-00883-8
|
| 318 |
Eira Cerda-Reyes, Alicia Sarahi Ojeda-Yuren, Julián Torres-Vazquez, María del Rosario Herrero Maceda, Martín Uriel Vázquez-Medina, Perla Denice Flores-Rangel, Yailin Fabiola Velásquez Palacios, Saraid Cerda-Reyes, Graciela Elia Castro-Narro. Advances in Hepatology. 2021; doi: 10.5772/intechopen.96281
|
| 319 |
Danielle Chi, Meghan Burk. What You Should Know About Fatty Liver Disease. ADCES in Practice 2020; 8(4): 34 doi: 10.1177/2633559X20928918
|
| 320 |
Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement. Expert Review of Anticancer Therapy 2022; 22(4): 371 doi: 10.1080/14737140.2022.2052276
|
| 321 |
Tony (Dazhong) Huang, Jason Behary, Amany Zekry. Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Internal Medicine Journal 2020; 50(9): 1038 doi: 10.1111/imj.14709
|
| 322 |
Valentin Blank, David Petroff, Sebastian Beer, Albrecht Böhlig, Maria Heni, Thomas Berg, Yvonne Bausback, Arne Dietrich, Anke Tönjes, Marcus Hollenbach, Matthias Blüher, Volker Keim, Johannes Wiegand, Thomas Karlas. Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75227-x
|
| 323 |
Amirreza Naseri, Sarvin Sanaie, Sina Hamzehzadeh, Sepideh Seyedi-Sahebari, Mohammad-Salar Hosseini, Elnaz Gholipour-khalili, Ehsan Rezazadeh-Gavgani, Reza Majidazar, Parya Seraji, Sara Daneshvar, Erfan Rezazadeh-Gavgani. Metformin: new applications for an old drug. Journal of Basic and Clinical Physiology and Pharmacology 2023; 34(2): 151 doi: 10.1515/jbcpp-2022-0252
|
| 324 |
J.M. Carrascosa, E. Vilarrasa, I. Belinchón, P. Herranz, J. Crespo, F. Guimerá, A. Olveira. Abordaje común del paciente con psoriasis y riesgo de esteatosis hepática metabólica: recomendaciones de un grupo de expertos multidisciplinar. Actas Dermo-Sifiliográficas 2023; 114(5): 392 doi: 10.1016/j.ad.2023.01.004
|
| 325 |
Yanqin Wang, Jiaqi Bo, Zhonghua Zhao, Yuhang Han, Qianqian Zhang, Lixin Liu. Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis. Life Sciences 2023; 332: 122086 doi: 10.1016/j.lfs.2023.122086
|
| 326 |
Rasika Pradeep Herath, Shirom R. Siriwardana, Chanil D. Ekanayake, Vikum Abeysekara, Sajith U. A. Kodithuwakku, Himali P. Herath, Jonathan M. Peterson. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study. PLOS ONE 2019; 14(4): e0215326 doi: 10.1371/journal.pone.0215326
|
| 327 |
Sarah Theurer, Julia Kälsch, Suzan Schwertheim, Simone Kathemann, Hideo A. Baba. Histopathologische Diagnostik und Differenzialdiagnostik der nichtalkoholischen Fettlebererkrankung. Der Pathologe 2020; 41(5): 434 doi: 10.1007/s00292-020-00800-0
|
| 328 |
Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis. Gene Expression 2019; 19(3): 187 doi: 10.3727/105221619X15553433838609
|
| 329 |
Ghulam Fatima, Kaneez Zainab Rabail, Mona Humaira, Afsana Khaskheli, Benazir Bughio, Kashaf Nida. Frequency of Liver Fibrosis by Non Invasive Marker in Patients with Non-Alcohol Fatty Liver Diseases. Pakistan Journal of Health Sciences 2023; : 99 doi: 10.54393/pjhs.v4i02.572
|
| 330 |
Jia Han, Xin Guo, Tomoyuki Koyama, Daichi Kawai, Jing Zhang, Reimon Yamaguchi, Xiaolei Zhou, Yoshiharu Motoo, Takumi Satoh, Sohsuke Yamada. Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse Model. Nutrients 2021; 13(10): 3455 doi: 10.3390/nu13103455
|
| 331 |
Chuanrui Ma, Xinyu Wang, Jing Zhang, Yun Zhao, Yunqing Hua, Chao Zhang, Guobin Zheng, Guangyan Yang, Jianli Guan, Huahuan Li, Meng Li, Lin Kang, Jiaqing Xiang, Guanwei Fan, Shu Yang. Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.893336
|
| 332 |
Vera Francisco, Maria Jesus Sanz, José T. Real, Patrice Marques, Maurizio Capuozzo, Djedjiga Ait Eldjoudi, Oreste Gualillo. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?. Biology 2022; 11(8): 1237 doi: 10.3390/biology11081237
|
| 333 |
Zahra Heidari, Zahra Sharafi. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iranian South Medical Journal 2022; 25(1): 30 doi: 10.52547/ismj.25.1.30
|
| 334 |
Vicki Shah, Thomas Colletti, Nancy Reau. Could the answer to NAFLD be hidden in diabetic therapy? The impact of T2DM treatment on NAFLD. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000100
|
| 335 |
Kaoru Shibayama, Chie Furushima, Minako Saka, Takako Sakamoto, Hirokazu Takahashi. Barriers to lifestyle modification in patients with non-alcoholic fatty liver disease: a scoping review. Journal of Rural Medicine 2024; 19(1): 1 doi: 10.2185/jrm.2023-026
|
| 336 |
Yan Li, Chunyi Wang, Yu Jin, Haibo Chen, Meiqun Cao, Weimin Li, Huanmin Luo, Zhengzhi Wu. Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats. Biomedicine & Pharmacotherapy 2020; 126: 109734 doi: 10.1016/j.biopha.2019.109734
|
| 337 |
José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, Claudia P. Oliveira. Non-pharmacological management options for MAFLD: a practical guide. Therapeutic Advances in Endocrinology and Metabolism 2023; 14 doi: 10.1177/20420188231160394
|
| 338 |
Vittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer. Nutrients 2023; 15(11): 2521 doi: 10.3390/nu15112521
|
| 339 |
Dana Gharib, Mohammed Mohammed, Taha Al-Karboly, Heero Faraj, Kawa Mahmood, Nasr Qazi, Karok Salih, Omar Azeez. VALUE OF TRANS-ABDOMINAL ULTRASOUND-GUIDED PERCUTANEOUS LIVER BIOPSY IN PATIENTS WITH FOCAL OR DIFFUSE LIVER LESIONS IN KURDISTAN CENTRE FOR GASTROENTEROLOGY AND HEPATOLOGY IN SULAIMANI CITY. JOURNAL OF SULAIMANI MEDICAL COLLEGE 2020; 10(2): 199 doi: 10.17656/jsmc.10258
|
| 340 |
Qing Gu, Li Cen, Jiawei Lai, Zhongchen Zhang, Jiaqi Pan, Feng Zhao, Chaohui Yu, Youming Li, Chunxiao Chen, Weixing Chen, Zhe Shen. A meta‐analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease. European Journal of Clinical Investigation 2021; 51(2) doi: 10.1111/eci.13446
|
| 341 |
Jun Noichi, Tomoko Ishiakawa, Ikuyo Ichi, Yoko Fujiwara. Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse model. Journal of Clinical Biochemistry and Nutrition 2022; 70(2): 140 doi: 10.3164/jcbn.21-69
|
| 342 |
Leyli Zahra Bahreini Boroujeni, Mohammad Mehdi Haghighat_Lari, Abolfazl Ghandi, Seyed Mahmood Hashemian, Rana Shafabakhsh, Zarrin Banikazemi, Mohsen Taghizadeh. Effects of black mulberry leaf extract on liver health and metabolic parameters in rats with high-fat diet-induced liver changes. Obesity Medicine 2024; 50: 100554 doi: 10.1016/j.obmed.2024.100554
|
| 343 |
Pierpaolo Pellicori, Muthiah Vaduganathan, João Pedro Ferreira, Faiez Zannad, Arun J. Sanyal. Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes & Metabolism 2022; 48(2): 101281 doi: 10.1016/j.diabet.2021.101281
|
| 344 |
Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, Michaela Noreik, Elizabeth Morris, Indrani Manoharan, Kate Tudor, Emma Bodenham, Anna Dunnigan, Susan A. Jebb, Paul Aveyard. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 2021; 115: 154455 doi: 10.1016/j.metabol.2020.154455
|
| 345 |
Xueqi Li, Wenjun Ma, Ting Yang, Chong Wang, Wei Zhang, Hui Li, Ting Zhao, Xiaofei Guo. Higher intakes of lysine, threonine and valine are inversely associated with non-alcoholic fatty liver disease risk: a community-based case-control study in the Chinese elderly. Food Science and Human Wellness 2024; 13(1): 191 doi: 10.26599/FSHW.2022.9250016
|
| 346 |
Haiyan Liu, Jie Xu, Hui Li, Lina Zhang, Pingzhen Xu. Network pharmacology‐based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease. The Anatomical Record 2021; 304(11): 2605 doi: 10.1002/ar.24770
|
| 347 |
Valeria Calcaterra, Vittoria Magenes, Matteo Vandoni, Clarissa Berardo, Luca Marin, Alice Bianchi, Erika Cordaro, Giustino Silvestro, Dario Silvestri, Vittoria Carnevale Pellino, Cristina Cereda, Gianvincenzo Zuccotti. Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity. Children 2022; 9(8): 1174 doi: 10.3390/children9081174
|
| 348 |
Swati Singh, Anit Kumar, Suruchi Gupta, Rohini Agrawal. Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD). Tissue Barriers 2024; 12(3) doi: 10.1080/21688370.2023.2289830
|
| 349 |
Maria Styliani Kalogirou, Olga Giouleme. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. World Journal of Transplantation 2022; 12(9): 281-287 doi: 10.5500/wjt.v12.i9.281
|
| 350 |
Kavita Garg, Scott Brackett, Irl B. Hirsch, Satish K. Garg. NAFLD/NASH and Diabetes. Diabetes Technology & Therapeutics 2020; 22(S1): S-174 doi: 10.1089/dia.2020.2513
|
| 351 |
Wanlu Su, Yuxia Wang, Kang Chen, Jie Wang, Anping Wang, Xulei Tang, Li Yan, Zuojie Luo, Guijun Qin, Lulu Chen, Guang Ning, Yiming Mu. Association between nonalcoholic fatty liver and increased low‐level albuminuria in postmenopausal women in China: A cross‐sectional study. Journal of Diabetes 2021; 13(6): 494 doi: 10.1111/1753-0407.13134
|
| 352 |
Feng-Zhi Xin, Ze-Hua Zhao, Rui-Nan Zhang, Qin Pan, Zi-Zhen Gong, Chao Sun, Jian-Gao Fan. Folic acid attenuates high-fat diet-induced steatohepatitis <i>via</i> deacetylase SIRT1-dependent restoration of PPARα. World Journal of Gastroenterology 2020; 26(18): 2203-2220 doi: 10.3748/wjg.v26.i18.2203
|
| 353 |
L. B. Lazebnik, E. V. Golovanova, S. V. Turkina, K. L. Raikhelson, S. V. Okovityy, O. M. Drapkina, I. V. Maev, A. I. Martynov, G. E. Roitberg, O. V. Khlynova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, A. O. Bueverov, E. V. Vinitskaya, G. V. Volynets, E. Yu. Eremina, V. B. Grinevich, A. I. Dolgushina, A. N. Kazyulin, E. I. Kashkina, I. V. Kozlova, Yu. V. Konev, N. V. Korochanskaya, Yu. A. Kravchuk, E. D. Li, I. D. Loranskaya, V. M. Makhov, S. N. Mekhtiev, V. P. Novikova, O. D. Ostroumova, Ch. S. Pavlov, V. G. Radchenko, A. A. Samsonov, A. S. Sarsenbaeva, R. G. Sayfutdinov, P. V. Seliverstov, S. I. Sitkin, O. V. Stefanyuk, L. V. Tarasova, E. I. Tkachenko, Yu. P. Uspensky, Yu. A. Fominykh, A. I. Khavkin, Yu. V. Tsyganova, O. O. Sharhun. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version. Experimental and Clinical Gastroenterology 2021; 1(1): 4 doi: 10.31146/1682-8658-ecg-185-1-4-52
|
| 354 |
Abdelilah Arredouani. Lifestyle-Related Diseases and Metabolic Syndrome. 2022; doi: 10.5772/intechopen.106445
|
| 355 |
Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway. Journal of Proteome Research 2020; 19(7): 2689 doi: 10.1021/acs.jproteome.9b00405
|
| 356 |
Elissa Lin, Aaron Justin Yeoh, Violeta Popov. Nutrition, Weight, and Digestive Health. 2022; : 207 doi: 10.1007/978-3-030-94953-2_13
|
| 357 |
Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, Nataliia Zavidniuk, Aleksandr Kamyshnyi. The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence. Viruses 2023; 15(5): 1072 doi: 10.3390/v15051072
|
| 358 |
Mohammad Yassin Zamanian, Mehraveh Sadeghi Ivraghi, Lusine G. Khachatryan, Diana E. Vadiyan, Hanie Yavarpour Bali, Maryam Golmohammadi. A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation. Food Science & Nutrition 2023; 11(12): 7485 doi: 10.1002/fsn3.3713
|
| 359 |
Yiling Qian, Yu Zhang, Xiaofang Fan, Hongmei Yan, Xuesong Li, Yujuan Fan, Yuping Song, Shuai Ma, Zheng Hu, Xin Gao, Jialin Yang. Nonalcoholic Fatty Liver Disease and Adverse Pregnancy Outcomes in Women With Normal Prepregnant Weight. The Journal of Clinical Endocrinology & Metabolism 2023; 108(2): 463 doi: 10.1210/clinem/dgac567
|
| 360 |
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
|
| 361 |
Emily Brown, T. Hydes, A. Hamid, D.J. Cuthbertson. Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. Clinical Therapeutics 2021; 43(9): 1476 doi: 10.1016/j.clinthera.2021.07.013
|
| 362 |
Farqad Abdulqader, Lennex Yu, Mark H. Vickers, Elwyn C. Firth, Sue R. McGlashan. Voluntary physical activity in early life attenuates markers of fatty liver disease in adult male rats fed a high-fat diet. British Journal of Nutrition 2023; 129(10): 1667 doi: 10.1017/S0007114522002562
|
| 363 |
Ja-Young Kwon. Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment. Clinical and Molecular Hepatology 2022; 28(1): 50 doi: 10.3350/cmh.2021.0359
|
| 364 |
Nick Finer. Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. Diabetes, Obesity and Metabolism 2022; 24(S2): 44 doi: 10.1111/dom.14569
|
| 365 |
Shih-Chieh Shao, Liang-Tseng Kuo, Rong-Nan Chien, Ming-Jui Hung, Edward Chia-Cheng Lai. SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews. BMJ Open Diabetes Research & Care 2020; 8(2): e001956 doi: 10.1136/bmjdrc-2020-001956
|
| 366 |
Kibo Nam, Mehnoosh Torkzaban, Dina Halegoua-DeMarzio, Corinne E Wessner, Andrej Lyshchik. Improving diagnostic accuracy of ultrasound texture features in detecting and quantifying hepatic steatosis using various beamforming sound speeds. Physics in Medicine & Biology 2023; 68(4): 04NT02 doi: 10.1088/1361-6560/acb635
|
| 367 |
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 2022; 12(2): 407 doi: 10.3390/diagnostics12020407
|
| 368 |
Jae Young Choi, Tae-Woo Jang, Phil Hyun Song, Seong Hoon Choi, Sae-Kwang Ku, Chang-Hyun Song. Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice. Antioxidants 2022; 11(3): 580 doi: 10.3390/antiox11030580
|
| 369 |
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, Katrin Bose, Peter R. Mertens, Christos Chatzikyrkou. Association of metabolic syndrome and chronic kidney disease. Obesity Reviews 2024; 25(1) doi: 10.1111/obr.13649
|
| 370 |
Sara Armani, Andreas Geier, Thomas Forst, Uta Merle, David H. Alpers, Martin W. Lunnon. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions. British Journal of Clinical Pharmacology 2024; 90(4): 942 doi: 10.1111/bcp.15990
|
| 371 |
Mohamed Abdel-Samiee, Essam Salah Ibrahim, Mohamed Kohla, Eman Abdelsameea, Mohsen Salama. Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics 2024; 15(6): 97381 doi: 10.4292/wjgpt.v15.i6.97381
|
| 372 |
Elaheh Zarean, Mehdi Azizmohammad Looha, Payam Amini, Ali Ahmadi, Pierre-Antoine Dugué. Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: findings from the Shahrekord PERSIAN cohort study. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-15251-4
|
| 373 |
Mohammad Bagher Majnooni, Mari Ataee, Gholamreza Bahrami, Fatemeh Heydarpour, Ina Yosifova Aneva, Mohammad Hosein Farzaei, Touraj Ahmadi‐Juoibari. The effects of co‐administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: A randomized clinical trial. Phytotherapy Research 2021; 35(11): 6324 doi: 10.1002/ptr.7279
|
| 374 |
Roberta Rinaldi, Sara De Nucci, Fabio Castellana, Martina Di Chito, Vito Giannuzzi, Endrit Shahini, Roberta Zupo, Luisa Lampignano, Giuseppina Piazzolla, Vincenzo Triggiani, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity. Nutrients 2023; 15(4): 825 doi: 10.3390/nu15040825
|
| 375 |
Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population. International Journal of Environmental Research and Public Health 2020; 17(10): 3518 doi: 10.3390/ijerph17103518
|
| 376 |
Véronique Cheff, Mayra Trentin-Sonoda, Amélie Blais, Jean-François Thibodeau, Chet E. Holterman, Alex Gutsol, Christopher R. J. Kennedy, Richard L. Hébert, Michael W. Greene. High fat diet is protective against kidney injury in hypertensive-diabetic mice, but leads to liver injury. PLOS ONE 2023; 18(2): e0281123 doi: 10.1371/journal.pone.0281123
|
| 377 |
Xiao Sun, Xinlei Wang, Lili Fu, Xiaoyan Wang, Lingxin Chen, Yan Huang. A Nanofluorescent Probe for Evaluating the Fluctuation of Aminopeptidase N in Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis. Analytical Chemistry 2024; 96(36): 14639 doi: 10.1021/acs.analchem.4c03298
|
| 378 |
David S. Mathiesen, Asger Lund, Tina Vilsbøll, Filip K. Knop, Jonatan I. Bagger. Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat. Frontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.617400
|
| 379 |
Laura Antonucci, Cristiana Porcu, Eleonora Timperi, Silvano Junior Santini, Gino Iannucci, Clara Balsano. Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity. Journal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/4570219
|
| 380 |
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers 2021; 13(4): 790 doi: 10.3390/cancers13040790
|